This post includes the full transcript of this week’s Beyond the Buzz episode, followed by the clarity poll and full evidence.

🎧INTRO

Welcome to Beyond the Buzz — where curiosity meets clarity.
I’m Dr. Tara Moroz, scientist and communicator with decades of experience translating complex human research into clear, evidence-informed insight.

This episode looks at natural health products and dietary supplements — from everyday vitamins to herbal products and concentrated extracts.

Maybe it is something you take every day, something you are thinking about trying, or something someone recommended.

Natural can make a product feel easier to trust. But does natural tell us enough to trust the claim?

Let’s take a closer look together — starting with what’s driving the buzz.

📊THE BUZZ

The buzz around natural health products is not just one claim. It can show up as a multivitamin for prevention, an herbal product for wellness, or a capsule that sounds more reassuring because the ingredient is familiar.

And this is not a small corner of health culture. In the United States, over 60% of adults age 20 and older used at least one dietary supplement in the past 30 days during August 2021 to August 2023 — about 6 out of 10 adults [H1].

The market is large too. One market analysis valued the global dietary supplements market at over 200 billion USD in 2025, with projected growth to over 430 billion USD by 2033 [H2].

So the public-facing question is practical. When a product is common, easy to buy, and surrounded by confident claims, people need a better filter than “natural” or “popular” [H1,H2].

When something is widely used and heavily marketed, it is worth asking what those messages leave out [H1,H2].

🧾RECEIPT CHECK

Let’s check the evidence — our kind of receipt check.

This is the moment to pause and ask the questions that matter — what’s the evidence, what’s the source, and how do we know?

🔬WHAT THE EVIDENCE SHOWS

Here’s what the evidence shows.

First, benefit depends on the product and the claim. Natural health products are not all the same. A vitamin, a mineral, an herb, and a concentrated extract can raise different evidence and safety questions [E1,E2,E3,E4,E5].

For vitamins and minerals used for primary prevention — trying to prevent disease before it starts — an updated systematic review examined prevention of cardiovascular disease and cancer [E1]. A systematic review is a study that reviews available research on a topic [E1].

The review found little or no benefit for preventing cancer, cardiovascular disease, or death for most vitamin and mineral supplements in healthy adults without known nutritional deficiencies [E1]. One example is multivitamins. The review found a small benefit for cancer incidence, but that finding sat within a broader picture of little or no benefit for preventing cancer, cardiovascular disease, or death overall [E1].

Another example goes the other way. Beta carotene was linked with increased lung cancer risk and other harmful outcomes in people at high risk of lung cancer [E1]. So a supplement can sound preventive and still raise a harm question in a specific group [E1].

Second, “natural” does not necessarily mean gentler. A natural source does not mean a product is harmless [E2,E3,E4]. Some supplements have been linked with health problems, and some can interact with medicines [E2,E3,E4].

Safety cannot be assumed just because something is sold without a prescription. One study estimated about 23,000 emergency department visits each year in the United States were related to dietary supplement adverse events [E2]. An adverse event is the formal term for a side effect or health problem reported after using a product [E2].

The examples matter. Emergency visits commonly involved heart-related symptoms from weight-loss or energy products in younger adults, and swallowing problems linked mostly with vitamin or mineral supplements in older adults [E2].

Green tea extract is a useful example. Guidance from the American Association for the Study of Liver Diseases includes green tea extract among herbal and dietary supplements associated with liver injury reports [E3].

Third, interactions matter. Herb–drug interactions — when an herb affects a medicine — have been evaluated across systematic reviews [E4].

St. John’s wort, an herbal product some people use for mood, is one example where serious interactions have been noted [E4]. Ginkgo and ginseng are other examples where interaction concerns have been reported, especially around medicines that affect bleeding, such as antiplatelet drugs or anticoagulants — medicines that reduce blood clotting [E4].

So the practical question is not only “does this work?” It is also “could this change how another medicine works?” [E4].

Online information can make supplement decisions harder. Online nutrition information can have quality and accuracy problems, and social media misinformation has been studied across topics including vaccines, drugs, diets, diseases, and medical treatments [E6,E7].

For supplement decisions, that can mean people are sorting through nutrition content and social media messages that vary in quality, accuracy, and certainty [E6,E7].

So the evidence reframes the question. It is not “natural health products: good or bad?” It is “what is the product, what is the claim, what is the evidence, and what safety question does it raise?” [E1,E2,E3,E4,E5,E6,E7].

🧠WHY THIS BUZZ RESONATES

So why does this resonate?

Part of the appeal may be that a supplement feels like something you can do right now. A bottle labeled for sleep, energy, or daily wellness can feel more concrete than uncertainty.

The message can also feel gentler. A familiar plant, vitamin, or mineral can make a product feel safer, simpler, or easier to trust.

And repetition matters emotionally. When the same claim shows up in a feed, a store, and a confident recommendation, it can start to feel sensible.

That is why this topic can feel confusing. The choice looks simple from the outside, but the better question takes more work.

🧭THE TAKEAWAY

Your Evidence Edit moment.
So what’s the takeaway?

Natural health products are not automatically worth it, and they are not automatically safe. “Natural” is not enough information on its own; the answer depends on the product, the claim, and the safety context [E1,E2,E3,E4,E5].

A broad prevention claim is different from a specific product claim, and a familiar ingredient can still raise safety questions in some supplement contexts [E1,E3,E4].

Before trusting a product because it sounds natural, ask three questions: what exactly is it claiming, what evidence matches that claim, and what safety or interaction issue needs checking [E1,E2,E3,E4,E5,E6,E7]?

Natural is not the decision. The claim is.

💭REFLECTION PROMPT

Something to reflect on…

When you hear a supplement claim, what detail do you notice first?

Is it the word natural?
The ingredient name?
The promise on the label?
The person recommending it?
The feeling that it seems harmless?

And what would change if the first question became: “What exact claim is this product making?”

📬OUTRO & CTA

If you found this useful, follow Beyond the Buzz and share it with a friend who likes a little science with their scroll.

You can also explore the full transcript, the clarity poll, and evidence in The Evidence Edit.

Until next time, stay curious — and stay kind to your mind.

This is Beyond the Buzz — cutting through the hype, because evidence is empowering.

Next week: Are Microplastics in Your Body Harmful?

📊 POLL

📚REFERENCES — What’s the Hype (H1–H#) / What’s the Evidence (E1–E#)

🔓 Open Access |🔒Paywalled

H1
Stierman, B., Couch, C. A., Gahche, J. J., & Mishra, S. (2026). Dietary supplement use: United States, August 2021–August 2023. NCHS Data Brief, 561, 1–11. Data period: United States, August 2021–August 2023. https://www.cdc.gov/nchs/products/databriefs/db561.htm

H2
Grand View Research. (2025). Dietary Supplements Market (2026 - 2033): Size, Share & Trends Analysis Report By Ingredients (Vitamin, Botanicals, Minerals, Proteins & Amino Acids), By Type, By Form, By Application, By End-user, By Distribution Channel, By Region, And Segment Forecasts. Grand View Research. Date of statistic if provided: 2025. https://www.grandviewresearch.com/industry-analysis/dietary-supplements-market-report

E1
O’Connor, E. A., Evans, C. V., Ivlev, I., Rushkin, M. C., Thomas, R. G., Martin, A., & Lin, J. S. (2022). Vitamin and Mineral Supplements for the Primary Prevention of Cardiovascular Disease and Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA, 327(23), 2334–2347. https://doi.org/10.1001/jama.2021.15650 🔓

E2
Geller, A. I., Shehab, N., Weidle, N. J., Lovegrove, M. C., Wolpert, B. J., Timbo, B. B., Mozersky, R. P., & Budnitz, D. S. (2015). Emergency Department Visits for Adverse Events Related to Dietary Supplements. The New England Journal of Medicine, 373(16), 1531–1540. https://doi.org/10.1056/NEJMsa1504267 🔓

E3
Fontana, R. J., Liou, I., Reuben, A., Suzuki, A., Fiel, M. I., Lee, W., & Navarro, V. (2023). AASLD practice guidance on drug, herbal, and dietary supplement-induced liver injury. Hepatology, 77(3), 1036–1065. https://doi.org/10.1002/hep.32689 🔓

E4
Posadzki, P., Watson, L. K., & Ernst, E. (2013). Herb–drug interactions: an overview of systematic reviews. British Journal of Clinical Pharmacology, 75(3), 603–618. https://doi.org/10.1111/j.1365-2125.2012.04350.x 🔓

E5
Kongkaew, C., Phan, D. T. A., Janusorn, P., & Mongkhon, P. (2024). Estimating Adverse Events Associated With Herbal Medicines Using Pharmacovigilance Databases: Systematic Review and Meta-Analysis. JMIR Public Health and Surveillance, 10, e63808. https://doi.org/10.2196/63808 🔓

E6
Denniss, E., Lindberg, R., & McNaughton, S. A. (2023). Quality and accuracy of online nutrition-related information: a systematic review of content analysis studies. Public Health Nutrition, 26(7), 1345–1357. https://doi.org/10.1017/S1368980023000873 🔓

E7
Suarez-Lledo, V., & Alvarez-Galvez, J. (2021). Prevalence of Health Misinformation on Social Media: Systematic Review. Journal of Medical Internet Research, 23(1), e17187. https://doi.org/10.2196/17187 🔓

🎧 Prefer to listen?
Listen to Are Natural Health Products Safe and Effective? on the Beyond the Buzz website — or follow Beyond the Buzz in your favourite podcast app.

Educational content only. This publication does not provide individualized medical, psychological, or professional advice.
Full disclaimer: beyondthebuzzmedia.com/disclaimer

This post includes the full transcript of this week’s Beyond the Buzz episode, followed by the clarity poll and full evidence.

🎧INTRO

Welcome to Beyond the Buzz — where curiosity meets clarity.

I’m Dr. Tara Moroz, scientist and communicator with decades of experience translating complex human research into clear, evidence-informed insight.

This episode looks at oral collagen supplements for skin, joints, and aging — because after Episode 23 on peptides, collagen stood out as the practical over-the-counter peptide question with modest, targeted benefits worth examining more closely.

Let’s do this together — starting with what’s driving the buzz.

📊THE BUZZ

The buzz is that oral collagen can support skin, joints, recovery, and aging.
One market report says more than 60 million consumers globally incorporate collagen supplements into daily routines [H1].

Another report valued the collagen supplements market at over 3 billion U.S. dollars in 2025, with estimates rising to close to 6 billion by 2031 [H2].

So this is not a fringe question [H1,H2].

The practical question is: what can I realistically expect if one product may promise skin benefits, joint health, post-exercise recovery, and aging support? [H1,H2]

🧾RECEIPT CHECK

Let’s check the evidence — our kind of receipt check.

This is the moment to pause and ask the questions that matter — what’s the evidence, what’s the source, and how do we know?

🔬WHAT THE EVIDENCE SHOWS

Here’s what the evidence shows.
For skin, the evidence is cautiously positive, but not transformational.

Reviews of randomized trials — studies that compare people taking collagen with people taking a look-alike product without active collagen — have found that oral collagen can improve measured skin hydration and elasticity [E1,E2,E5].

Some reviews also found improvement in wrinkle measures when results from several trials were combined [E1,E2]. But a 2025 review was more cautious when it looked only at better-designed studies, or studies that were not funded by pharmaceutical companies [E1].

Most of the skin evidence studied hydrolyzed collagen, also called collagen peptides [E2]. The studies do not point to one best dose. They used doses ranging roughly from 0.6 grams to 12 grams per day [E2].

For someone comparing products, that means a daily dose in the few-grams-to-about-10-grams range is easier to compare with the skin evidence than a vague “beauty collagen” claim [E2].

And for skin, daily use for about 8 to 12 weeks is a more realistic timeframe before judging whether the benefit feels worth it [E2].

Hydration, elasticity, and wrinkle measures are real skin outcomes, but they are often measured with instruments — not by whether someone sees noticeable change in the mirror [E2].

So for skin, collagen may help with measured changes like hydration and elasticity, but the practical question is whether that kind of change matches the cost and expectation [E1,E2,E5].

For knee osteoarthritis, the evidence is more specific than a general joint-health claim.
The trials included people with knee osteoarthritis and measured pain using rating scales, like asking people how much their knee hurt [E3].
The meta-analysis found greater pain relief with collagen peptides than placebo, but all included studies were judged at high risk of bias [E3].
So if you are buying collagen for joints, the evidence lines up better with osteoarthritis symptom relief than with broad claims about joint support, cartilage repair, or prevention [E3,E5].

For training, collagen looks most relevant as an add-on to exercise.
A systematic review with meta-analysis found benefits from collagen peptides plus regular training for fat-free mass, tendon morphology, muscle architecture, maximal strength, and 48-hour reactive-strength recovery [E4].
Fat-free mass means body mass that is not fat.
The certainty ranged from moderate for body composition to low or very low for several other outcomes [E4].
The authors’ practical rationale was 15 grams of collagen peptides daily for at least 8 weeks, alongside training at least twice weekly — such as resistance training, or body-weight exercise combined with running [E4].

So this is not a shortcut.
It is a possible training-support tool, with modest and specific expectations [E4].

Across the evidence, the pattern is clear: collagen supplements may offer some benefits, but the strongest claims are specific [E1,E2,E3,E4,E5].

Skin hydration is not the same as looking younger.
Knee osteoarthritis pain is not the same as general joint health.
Training support is not the same as broad anti-aging [E1,E2,E3,E4,E5].

🧠WHY THIS BUZZ RESONATES

So why does this resonate?

Part of the appeal may be that collagen feels like a low-friction choice.
It can feel easy to add and easy to understand.
The promise can land because it offers a small action with the hope of a visible or physical payoff.
The tension is not only what the product says.
It is what we start to expect from it.

🧭THE TAKEAWAY

Your Evidence Edit moment.

So what’s the takeaway?

Collagen is not automatically a bad buy, but it is best understood as a specific-outcome supplement, not a broad anti-aging solution [E1,E2,E3,E4,E5].

What holds up is a modest, cautiously positive signal for skin hydration and elasticity, a narrower signal for osteoarthritis symptom relief, and a training-linked signal when collagen peptides are paired with regular exercise [E1,E2,E3,E4,E5].

What we do not know is whether every product, dose, source, routine, or person will get the same result [E1,E2,E3,E4,E5].

A reasonable shelf test is to ask: what outcome am I buying this for, and does the label make the form, dose, and timeframe easy to compare with the evidence? [E1,E2,E3,E4,E5]

If the goal is simply to “support aging,” the promise is too broad to know what outcome you are buying — or whether the product is likely to give you the result you want [E1,E2,E3,E4,E5].

💭REFLECTION PROMPT

Something to reflect on…

When you see a collagen claim, what change are you actually expecting?
Is the product promising a specific outcome, or a general feeling of aging better?

And does that expectation match what you would consider worth your time, money, attention, or concern?

📬OUTRO & CTA

If you found this useful, follow Beyond the Buzz and share it with a friend who likes a little science with their scroll.

You can also explore the full transcript, the clarity poll, and evidence in The Evidence Edit.

Until next time, stay curious — and stay kind to your mind.

This is Beyond the Buzz — cutting through the hype, because evidence is empowering.

Next week: Are Natural Health Products Safe and Effective?

📊 POLL

📚REFERENCES — What’s the Hype (H1–H#) / What’s the Evidence (E1–E#)

🔓 Open Access |🔒Paywalled

H1
Fortune Business Insights. (2026, June 01). Collagen Supplements Market Size, Share & Industry Analysis, By Source (Bovine, Marine, Porcine, Poultry, and Others), By Function (Skin Health, Joint & Bone Health, Hair & Nail Health, Sports Nutrition, General Wellness, Gut Health, and Others), By Form (Powder, Capsules/Tablets, Liquid, Gummies, Softgels, and Others), By Collagen Type (Type I, Type II, Type III, Type IV & V, and Multi-collagen Blends), By Distribution Channel (Supermarkets/Hypermarkets, Pharmacies & Drug Stores, Specialty Stores, Online Retail, and Others), and Regional Forecast, 2026-2034. Fortune Business Insights. Last Updated: June 01, 2026. https://www.fortunebusinessinsights.com/collagen-supplements-market-106539

H2
Mordor Intelligence. (2026). Collagen Supplements Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2031). Mordor Intelligence. Date of statistic if provided: 2025; 2026; forecast period 2026–2031. https://www.mordorintelligence.com/industry-reports/collagen-supplements-market

E1
Myung, S.-K., & Park, Y. (2025). Effects of Collagen Supplements on Skin Aging: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. The American Journal of Medicine, 138(9), 1264–1277. https://doi.org/10.1016/j.amjmed.2025.04.034 🔒

E2
Pu, S.-Y., Huang, Y.-L., Pu, C.-M., Kang, Y.-N., Hoang, K. D., Chen, K.-H., & Chen, C. (2023). Effects of Oral Collagen for Skin Anti-Aging: A Systematic Review and Meta-Analysis. Nutrients, 15(9), 2080. https://doi.org/10.3390/nu15092080 🔓

E3
Lin, C.-R., Tsai, S. H. L., Huang, K.-Y., Tsai, P.-A., Chou, H., & Chang, S.-H. (2023). Analgesic efficacy of collagen peptide in knee osteoarthritis: a meta-analysis of randomized controlled trials. Journal of Orthopaedic Surgery and Research, 18(1), 694. https://doi.org/10.1186/s13018-023-04182-w 🔓

E4
Bischof, K., Moitzi, A. M., Stafilidis, S., & König, D. (2024). Impact of Collagen Peptide Supplementation in Combination with Long-Term Physical Training on Strength, Musculotendinous Remodeling, Functional Recovery, and Body Composition in Healthy Adults: A Systematic Review with Meta-analysis. Sports Medicine, 54(11), 2865–2888. https://doi.org/10.1007/s40279-024-02079-0 🔓

E5
Ravindran, R., Pizzol, D., López-Gil, J. F., Rahmati, M., Boyer, L., Fond, G., Butler, L., Stellato, A., Gawronska, J., Barnett, Y., Soysal, P., Eren, R., Onal, B., Yon, D. K., & Smith, L. (2026). Collagen Supplementation for Skin and Musculoskeletal Health: An Umbrella Review of Meta-Analyses on Elasticity, Hydration, and Structural Outcomes. Aesthetic Surgery Journal Open Forum, 8, ojag018. https://doi.org/10.1093/asjof/ojag018 🔓

🎧 Prefer to listen?
Listen to Do Collagen Supplements Actually Work? on the Beyond the Buzz website — or follow Beyond the Buzz in your favourite podcast app.

Educational content only. This publication does not provide individualized medical, psychological, or professional advice.
Full disclaimer: beyondthebuzzmedia.com/disclaimer

This post includes the full transcript of this week’s Beyond the Buzz episode, followed by the clarity poll and full evidence.

Thank you to this week’s guest, Dr. Adrian Wagg, Professor of Medicine, University of Alberta.

🎧INTRO

Welcome to Beyond the Buzz — where curiosity meets clarity.

I’m Dr. Tara Moroz, scientist and communicator with decades of experience translating complex human research into clear, evidence-informed insight.

This episode looks at bladder leakage, pelvic floor exercises, and treatment options — because the message can swing between “it’s normal, live with it” and “try this fix.”

Maybe leakage is affecting exercise, sleep, travel, confidence, or daily routines.

That can leave people unsure whether to ignore it, search for answers, or ask for help.

Mixed messages can waste time, money, attention, and concern when a private health question gets reduced to one-size-fits-all advice.

To bring a clinical perspective into this conversation, I spoke with Dr. Adrian Wagg, an internationally recognized incontinence expert from the University of Alberta, whose work includes bladder health and incontinence in aging.

Full disclosure: Dr. Wagg is also my husband.

Let’s take a closer look together — starting with what’s driving the buzz.

📊THE BUZZ

Urinary incontinence means leaking urine when you do not mean to [E1].
The online question is not just, “Is this common?”
It is, “Is this something I just have to live with?”
That question matters because urinary incontinence is common [H1].

One large U.S. survey analysis focused on women aged 20 and older found that 63% reported urinary incontinence, or about 6 out of 10 women [H1].
That represented almost 80 million U.S. women [H1].

The cost is also substantial [H2].
Across EU countries, the estimated 2023 economic burden was almost €70 billion [H2].
That analysis included both males and females, while finding that females carried about four times the burden of males [H2].

So the buzz is understandable [H1,H2].
When something is common, costly, private, and surrounded by simple messages, it is worth asking what those messages leave out [H1,H2].

🧾RECEIPT CHECK

Let’s check the evidence — our kind of receipt check.

This is the moment to pause and ask the questions that matter — what’s the evidence, what’s the source, and how do we know?

🔬WHAT THE EVIDENCE SHOWS

Here’s what the evidence shows.

The evidence points in two directions: urinary incontinence is common in women [H1], and treatment options exist [E1,E2,E4,E5].
A lot of the evidence we’re looking at here focuses on women, especially pelvic floor muscle training and stress leakage [H1,E1,E2,E3,E5].

A Cochrane overview found a wide evidence base for conservative treatment of urinary incontinence in women [E1].
Conservative treatment means non-surgical treatment [E1].
Pelvic floor muscle training is one of the best-supported conservative options [E1,E2].
Pelvic floor muscle training means exercises for the muscles that help support bladder control [E2].
A Cochrane review comparing pelvic floor muscle training with no treatment or inactive control treatments found that it can cure or improve symptoms in women with stress urinary incontinence and other types of urinary incontinence [E2].
That gives pelvic floor exercises real evidence weight, not just wellness buzz [E1,E2].
But pelvic floor exercises are not the whole story [E1,E3,E4,E5].
A 2024 Cochrane review compared different ways of doing pelvic floor muscle training [E3].
That matters because the evidence is not only about whether pelvic floor training can help, but also about how it is delivered and supported [E3].

The type of leakage also matters [E4,E5].
Stress urinary incontinence means leaking with pressure or exertion, such as movement, coughing, or physical activity [E5].
Overactive bladder is a different symptom pattern, linked to urgency, frequency, and sometimes urgency leakage [E4].

So the practical answer is not “just do Kegels” and not “nothing can be done” [E1,E2,E4,E5].
The better answer is: identify the leakage pattern, then match the treatment discussion to that pattern [E4,E5].

🧠WHY THIS BUZZ RESONATES

So why does this resonate?

Because both messages offer a kind of relief.
“It’s normal, live with it” can make leakage feel less alarming.
“Try this fix” can make it feel solvable without an awkward conversation.

One message says leakage is just part of pregnancy, exercise, menopause, aging, or having a body.

Another says one exercise routine can fix everything.

That combination can be powerful when something feels private, inconvenient, or easy to minimize.

The tension is that both messages can sound useful while still leaving people unsure what applies to them.

That is why this topic sits between everyday reassurance, online searching, and one-size-fits-all advice.

So I wanted to ask what this looks like in real clinical life.

🧭 GUEST INSIGHTS AND THE TAKEAWAY

To explore that, I spoke with Dr. Wagg.

Dr. Wagg, when people ask whether bladder leakage is something they just have to live with, what do you wish more people understood?
[Dr. Wagg: Many people believe that bladder leaks are a normal part of being a woman or getting older. Because of this, some people “just live with it.” They may buy pads, avoid going out, plan their day around bathrooms, or change their lifestyle in ways that are frustrating or inconvenient. But leaking urine is not something people should simply accept. It is common, but it is not normal. Getting advice early can help.]

Bladder leakage is often talked about as part of aging, but it can happen for different reasons. What is helpful — and what is unhelpful — about the aging message?
[Dr. Wagg: In older adults, bladder leaks are often not caused by aging. They may be linked to other health problems, such as heart disease, constipation, Parkinson’s disease, memory problems, or trouble getting around. Some medicines can also make bladder leaks worse. For this reason, it is usually better to look for the cause rather than saying, “It’s just aging.”]

A lot of online advice jumps straight to pelvic floor exercises. When are pelvic floor exercises useful, and when is that message too simple?
[Dr. Wagg: Pelvic floor muscle exercises can help many people. These exercises can help support the bladder in people with stress incontinence. They can also help people with urgency incontinence by making it easier to hold urine for longer. People usually get the best results when they are taught how to do the exercises properly and have follow-up support. However, pelvic floor exercises are only one part of treatment. They can take at least four months to make a clear difference. They also work best when combined with other treatments that address the bladder problem and any other health issues that may be making the leaking worse.]

The evidence separates stress urinary incontinence from overactive bladder symptoms. In plain language, how should people think about that difference?
[Dr. Wagg: There are different types of bladder leakage. Stress incontinence happens when urine leaks during physical pressure or movement. This might happen with coughing, laughing, sneezing, lifting, or exercise. It is more common in women, and it can also happen in men after prostate surgery. Overactive bladder is different. It causes a sudden, strong need to pass urine that is hard to put off. This is called urgency. Sometimes people leak urine before they reach the toilet. These types of bladder problems are treated in different ways. That is why it is important to understand what is causing the leakage before choosing a treatment.]

And if someone has been quietly putting up with leakage for months or years, what would you want their next step to be?
[Dr. Wagg: People should feel able to speak up and ask for help. A family doctor, nurse, physiotherapist, or other health care provider can give advice. Online symptom checkers or self-help questionnaires may also help people prepare for a conversation with their health care provider. Bladder leakage is still a topic many people feel embarrassed to talk about. But it is a health problem, and help is available. There are many things that can be done to improve symptoms and make life better.]

Thank you, Dr. Wagg — and yes, full disclosure again, I do also get to ask him these questions at home.

Your Evidence Edit moment.
So what’s the takeaway?

Urinary leakage is common, and the evidence supports treating it as a health issue with options, not as something people simply have to accept [H1,E1,E2,E4,E5].
Pelvic floor muscle training is one evidence-supported option, particularly in women and as part of conservative treatment [E1,E2].

Treatment can also include broader guideline-based discussions, depending on whether the pattern is stress urinary incontinence or overactive bladder [E4,E5].
What we don’t know from a simple social post is which pattern someone has, which approach fits best, or whether pelvic floor training alone is enough [E3,E4,E5].

A reasonable decision lens is to ask three questions: what kind of leakage is this, what options fit that pattern, and what are the tradeoffs [E4,E5].
That is where a real clinical conversation can help: identifying the leakage pattern, discussing the options, and weighing the tradeoffs [E4,E5].

Common is not inevitable; treatment is not one-size-fits-all.

💭REFLECTION PROMPT

Something to reflect on…
When you hear a simple message about bladder leaks, does it help you understand the pattern?
Or does it make one answer sound like the whole story?

📬OUTRO & CTA

If you found this useful, follow Beyond the Buzz and share it with a friend who likes a little science with their scroll.

You can also explore the full transcript, the clarity poll, and evidence in The Evidence Edit.

Until next time, stay curious — and stay kind to your mind.

This is Beyond the Buzz — cutting through the hype, because evidence is empowering.

Next week: Do Collagen Supplements Actually Work?

📊 POLL

📚REFERENCES — What’s the Hype (H1–H#) / What’s the Evidence (E1–E#)

🔓 Open Access |🔒Paywalled

H1

Che, R., Simpson, R., Akbar, Z., Gilliam, K., Ahmed, A., & Farhan, B. (2026). Post-Pandemic Prevalence of Urinary Incontinence Among Women in the United States and Associated Risk Factors. International Urogynecology Journal, 37(3), 583–595. https://doi.org/10.1007/s00192-025-06280-1 🔒

H2

Bishop, C., Rodriguez-Cairoli, F., Hagens, A., Bermudez, M. A., Van Kerrebroeck, P., & Collen, S. (2025). Prevalence, Socioeconomic, and Environmental Costs of Urinary Incontinence in the European Union. European Urology, 88(2), 157–166. https://doi.org/10.1016/j.eururo.2025.05.025 🔓

E1

Todhunter-Brown, A., Hazelton, C., Campbell, P., Elders, A., Hagen, S., & McClurg, D. (2022). Conservative interventions for treating urinary incontinence in women: an Overview of Cochrane systematic reviews. Cochrane Database of Systematic Reviews, 2022(9), CD012337. https://doi.org/10.1002/14651858.CD012337.pub2 🔓

E2

Dumoulin, C., Cacciari, L. P., & Hay-Smith, E. J. C. (2018). Pelvic floor muscle training versus no treatment, or inactive control treatments, for urinary incontinence in women. Cochrane Database of Systematic Reviews, 2018(10), CD005654. https://doi.org/10.1002/14651858.CD005654.pub4 🔓

E3

Hay-Smith, E. J. C., Starzec-Proserpio, M., Moller, B., Aldabe, D., Cacciari, L., Pitangui, A. C. R., Vesentini, G., Woodley, S. J., Dumoulin, C., Frawley, H. C., Jorge, C. H., Morin, M., Wallace, S. A., & Weatherall, M. (2024). Comparisons of approaches to pelvic floor muscle training for urinary incontinence in women. Cochrane Database of Systematic Reviews, 2024(12), CD009508. https://doi.org/10.1002/14651858.CD009508.pub2 🔓

E4
Nambiar, A. K., Arlandis, S., Bø, K., Cobussen-Boekhorst, H., Costantini, E., de Heide, M., Farag, F., Groen, J., Karavitakis, M., Lapitan, M. C. M., Omar, M. I., Peyronnet, B., Sakalis, V. I., Sihra, N., & Harding, C. K. (2022). European Association of Urology guidelines on the diagnosis and management of female non-neurogenic lower urinary tract symptoms. Part 1: Diagnostics, overactive bladder, stress urinary incontinence, and mixed urinary incontinence. European Urology, 82(1), 49–59. https://doi.org/10.1016/j.eururo.2022.01.045 🔓

E5

Carlson, K., Andrews, M., Bascom, A., Baverstock, R., Campeau, L., Dumoulin, C., Labossiere, J., Locke, J. A., Nadeau, G., & Welk, B. (2024). 2024 Canadian Urological Association guideline: Female stress urinary incontinence. Canadian Urological Association Journal, 18(4), 83–102. https://doi.org/10.5489/cuaj.8751 🔓

🎧 Prefer to listen?
Listen to Are Bladder Leaks Normal or Treatable? on the Beyond the Buzz website — or follow Beyond the Buzz in your favourite podcast app.

Educational content only. This publication does not provide individualized medical, psychological, or professional advice.
Full disclaimer: beyondthebuzzmedia.com/disclaimer

This post includes the full transcript of this week’s Beyond the Buzz episode, followed by the clarity poll and full evidence.

🎧INTRO

Welcome to Beyond the Buzz — where curiosity meets clarity.

I’m Dr. Tara Moroz, scientist and communicator with decades of experience translating complex human research into clear, evidence-informed insight.

This episode looks at perimenopause symptoms, hormone testing, and clinical diagnosis — because when symptoms are real, changing, and hard to explain, the idea of a blood test can feel worth exploring.
If this is on your mind, it may be because you want something clearer than guesswork: a number, a label, or a reason for what is happening.
That makes it worth asking what a blood test can tell us — and what it cannot.

Let’s take a closer look together — starting with what’s driving the buzz.

📊THE BUZZ

The buzz is that a hormone test — usually a blood test — can tell you whether you’re in perimenopause.

Perimenopause is the transition toward menopause, and menopause is confirmed after 12 months without a period. [E1,E2,E6]

Symptoms can start before menopause is formally confirmed. During perimenopause, they may include hot flashes and night sweats, also called vasomotor symptoms. [E1,E5]

One pooled estimate found hot flashes in almost 60% of middle-aged women in perimenopause. [H1]

The workplace stakes are real too: a U.S. survey-based economic analysis estimated almost 2 billion dollars in annual loss from missed workdays due to menopause symptoms. [H2]

When symptoms show up at this scale and the costs are substantial, the wish for a clearer answer is understandable. [H1,H2]
That is where the simple blood-test promise comes in: one number that seems like it could explain what is happening.

🧾RECEIPT CHECK

Let’s check the evidence — our kind of receipt check.

This is the moment to pause and ask the questions that matter — what’s the evidence, what’s the source, and how do we know?

🔬WHAT THE EVIDENCE SHOWS

Here’s what the evidence shows.

The strongest pattern is practical: for many women in the usual midlife age range, perimenopause is identified from symptoms and menstrual cycle changes, not from routine hormone panels. [E1,E2,E3]

The European Society of Endocrinology guideline says routine hormone blood tests are not needed to diagnose or manage perimenopause or menopause in women older than 45. [E1]

NICE, the National Institute for Health and Care Excellence, is a UK health-guidance body. It also centers identification and management on clinical assessment, which means a health professional considers the person’s symptoms, age, and menstrual pattern. [E2]
Clinical assessment means using the health story and exam context. [E1,E2]

Hormone levels can fluctuate during this transition, so one result may not settle the question. [E1,E5,E6]

FSH, or follicle-stimulating hormone, is a hormone signal from the brain that helps regulate ovulation. [E1,E6]
FSH testing can be considered in women aged 40 to 45 with symptoms, and it is recommended when premature ovarian insufficiency is suspected under the age of 40. [E1,E2]

Premature ovarian insufficiency means ovaries slow earlier than expected. [E1,E2]
AMH, or anti-Müllerian hormone, is a marker linked with how many eggs remain in the ovaries. [E4]
A systematic review — a study that reviews available research — found AMH was associated with timing of menopause, yet AMH alone could not predict menopause age closely enough to give a clear personal timeline. [E4]
That same review found no evidence that AMH testing could replace the 12 months without a menstrual period used to formally diagnose menopause. [E4]

So the evidence does not support AMH as a simple yes-or-no test for menopause timing. [E4]

Reproductive aging is best seen as stages based on menstrual patterns, with hormones as supportive markers rather than giving the whole answer. [E6]

🧠WHY THIS BUZZ RESONATES

So why does this resonate?

Because real symptoms can be hard to explain.
A blood test can seem to offer something simpler: one number, one label, one reason.
That can feel especially appealing when symptoms are disruptive, scattered, or easy for other people to minimize.
The promise is not just information.
It is validation.
It can feel like a way to make an uncertain body experience visible, nameable, and easier to talk about.
That is why the hormone-testing message can land so strongly.

🧭THE TAKEAWAY

Your Evidence Edit moment.

So what’s the takeaway?

For typical midlife symptoms and changing periods, the strongest evidence supports clinical diagnosis over routine hormone testing. [E1,E2,E3]
In plain language, the health story often matters more than a blood test. [E1,E2,E6]

Hormone testing has a narrower role, especially around younger ages or possible premature ovarian insufficiency. [E1,E2]

AMH may relate to menopause timing across groups, but the evidence does not support using AMH alone to give one person a precise forecast of when menopause will happen. [E4]

It’s more reasonable to ask whether testing would change the next step in your care, or simply add another number to interpret. [E1,E2,E3]

It may be worth giving more attention to symptoms, cycle pattern, and a shared conversation about options. [E1,E2,E3]

Start with the pattern, ask what the test would change, and keep the person — not the lab number — at the center.

💭REFLECTION PROMPT

Something to reflect on…
When you hear a claim that a hormone test can finally explain perimenopause, what would you want that test to change: your understanding, your care options, your peace of mind, or all three?

And if the result would not change the next step, what other evidence from your own pattern might deserve attention?

📬OUTRO & CTA

If you found this useful, follow Beyond the Buzz and share it with a friend who likes a little science with their scroll.

You can also explore the full transcript, the clarity poll, and evidence in The Evidence Edit.

Until next time, stay curious — and stay kind to your mind.

This is Beyond the Buzz — cutting through the hype, because evidence is empowering.

Next week: Are Bladder Leaks Normal or Treatable?

📊 POLL

📚REFERENCES — What’s the Hype (H1–H#) / What’s the Evidence (E1–E#)

🔓 Open Access |🔒Paywalled

H1
Fang, Y., Liu, F., Zhang, X., Chen, L., Liu, Y., Yang, L., Zheng, X., Liu, J., Li, K., & Li, Z. (2024). Mapping global prevalence of menopausal symptoms among middle-aged women: a systematic review and meta-analysis. BMC Public Health, 24, 1767. https://doi.org/10.1186/s12889-024-19280-5 🔓

H2
Faubion, S. S., Enders, F., Hedges, M. S., Chaudhry, R., Kling, J. M., Shufelt, C. L., Saadedine, M., Mara, K., Griffin, J. M., & Kapoor, E. (2023). Impact of Menopause Symptoms on Women in the Workplace. Mayo Clinic Proceedings, 98(6), 833–845. https://doi.org/10.1016/j.mayocp.2023.02.025 🔒

E1
Lumsden, M. A., Dekkers, O. M., Faubion, S. S., Hirschberg, A. L., Jayasena, C. N., Lambrinoudaki, I., Louwers, Y., Pinkerton, J. V., Sojat, A. S., & van Hulsteijn, L. (2025). European Society of Endocrinology clinical practice guideline for evaluation and management of menopause and the perimenopause. European Journal of Endocrinology, 193(4), G49–G81. https://doi.org/10.1093/ejendo/lvaf206 🔓

E2
National Institute for Health and Care Excellence. (2026). Menopause: identification and management. NICE guideline, NG23. https://www.nice.org.uk/guidance/ng23 🔓

E3
British Menopause Society, Royal College of Obstetricians and Gynaecologists, Society for Endocrinology, College of Sexual and Reproductive Healthcare, Faculty of Pharmaceutical Medicine, & Royal Pharmaceutical Society. (2026). Menopause Practice Standards. British Menopause Society, 1–13. https://thebms.org.uk/wp-content/uploads/2026/05/NEW-BMS-Menopause-Practice-Standards-MAY2026-A.pdf 🔓

E4
Nelson, S. M., Davis, S. R., Kalantaridou, S., Lumsden, M. A., Panay, N., & Anderson, R. A. (2023). Anti-Müllerian hormone for the diagnosis and prediction of menopause: a systematic review. Human Reproduction Update, 29(3), 327–346. https://doi.org/10.1093/humupd/dmac045 🔓

E5
Santoro, N., Roeca, C., Peters, B. A., & Neal-Perry, G. (2021). The Menopause Transition: Signs, Symptoms, and Management Options. The Journal of Clinical Endocrinology & Metabolism, 106(1), 1–15. https://doi.org/10.1210/clinem/dgaa764 🔓

E6
Harlow, S. D., Gass, M., Hall, J. E., Lobo, R., Maki, P., Rebar, R. W., Sherman, S., Sluss, P. M., Broekmans, F. J. M., STRAW + 10 Collaborative Group, & de Villiers, T. J. (2012). Executive Summary of the Stages of Reproductive Aging Workshop + 10: Addressing the Unfinished Agenda of Staging Reproductive Aging. The Journal of Clinical Endocrinology & Metabolism, 97(4), 1159–1168. https://doi.org/10.1210/jc.2011-3362 🔓

🎧 Prefer to listen?
Listen to Can a Blood Test Diagnose Perimenopause? on the Beyond the Buzz website — or follow Beyond the Buzz in your favourite podcast app.

Educational content only. This publication does not provide individualized medical, psychological, or professional advice.
Full disclaimer: beyondthebuzzmedia.com/disclaimer

This post includes the full transcript of this week’s Beyond the Buzz episode, followed by the clarity poll and full evidence.

🎧INTRO

Welcome to Beyond the Buzz — where curiosity meets clarity.
I’m Dr. Tara Moroz, scientist and communicator with decades of experience translating complex human research into clear, evidence-informed insight.

Today we’re looking at mental health self-diagnosis, symptom interpretation, and how accurate online mental health information really is.
A lot of people are trying to understand difficult feelings, stress, attention, burnout, or anxiety in everyday life.
And mixed messages online can make people spend emotional energy trying to label normal experiences or interpret symptoms alone.
Sometimes certainty online feels easier than uncertainty in real life.

Let’s take a closer look together — starting with what’s driving the buzz.

📊THE BUZZ

Spend a few minutes online and mental health language is everywhere.
ADHD, trauma, anxiety, autism, burnout, depression — the words show up in videos, captions, comments, and quizzes.

And for many people, this content is not just something to watch. It becomes a way to interpret themselves. [H1]

One 2025 survey reported that nearly one-third of respondents said they had self-diagnosed a mental health condition based on information they saw online. [H1]

At the same time, the business around digital mental health tools is growing quickly. [H2]
One market report estimated the global mental health apps market at about 7.5 billion U.S. dollars in 2024, with continued rapid growth projected through 2030. [H2]

That growth reflects something real.
People are looking for language, reassurance, and a way to make sense of experiences that can feel hard to explain.

🧾RECEIPT CHECK

Let’s check the evidence — our kind of receipt check.

This is the moment to pause and ask the questions that matter — what’s the evidence, what’s the source, and how do we know?

🔬WHAT THE EVIDENCE SHOWS

Here’s what the evidence shows.

A systematic review — a study that reviews available research on a topic — found that mental health and neurodivergence content on social media varies widely in quality and reliability. [E1]
The review also found examples of misinformation, oversimplified symptom descriptions, and content that sometimes blurred the line between education, identity, and diagnosis. [E1]

That does not mean all online mental health content is wrong.
Some tools and questionnaires can help identify people who may need further assessment. [E2][E3]

But most screening tools are designed for screening, not diagnosis. [E2][E3]
That distinction matters.

For example, the PHQ-9 — a common depression questionnaire — has been studied extensively as a screening tool for major depression. [E4]
And the GAD-7 — a common anxiety questionnaire — has been studied as a screening tool for anxiety disorders. [E5]

Screening means identifying people who might need more evaluation.
It does not mean confirming a diagnosis on its own. [E2][E3][E4][E5]

The evidence also shows that digital psychiatry tools vary in accuracy and validation. [E2]
Some appear promising in certain settings, while others have limited evidence or inconsistent performance. [E2]

And this brings us to another important part of the conversation: overdiagnosis.

Overdiagnosis means identifying a condition in ways that may not improve health or may label normal variation as disorder. [E6]

Researchers in mental health have raised concerns about how diagnostic boundaries can expand over time. [E6][E7]
Some symptoms can overlap with stress, grief, personality, sleep problems, life transitions, or normal emotional variation. [E6][E7]

And that context is often missing from short-form online content. [E1]

🧠WHY THIS BUZZ RESONATES

So why does this trend resonate?

Because mental health language can feel clarifying.
It can give people words for experiences that felt confusing or hard to explain.
And when someone has been struggling, a short video or symptom list can feel like a door opening.
There is relief in thinking,
“Oh — maybe this explains me.”
That does not mean the explanation is wrong.
But it also does not mean it is complete.

Sometimes, a label can help someone feel less alone or seek support.

But a label can also become a shortcut, especially when normal stress, grief, sleep loss, personality, burnout, and life transitions can overlap with mental health symptoms.

Online, that nuance can be hard to hold onto.

🧭THE TAKEAWAY

So what’s the takeaway?

The strongest evidence supports a careful distinction: online mental health content and screening tools can help people recognize possible symptoms, but they are not substitutes for full clinical assessment. [E1][E2][E3][E4][E5]
Some screening questionnaires can help identify people who may need further evaluation, while social media content varies greatly in quality and can oversimplify complex experiences. [E1][E2][E3][E4][E5]
The evidence also suggests that concerns about overdiagnosis and labeling normal emotional variation are legitimate parts of this discussion. [E6][E7]

It can feel difficult separating insight from identity online.

A useful next step is to treat online mental health content as a starting point for reflection — not the final answer. If a symptom is persistent, distressing, or affecting daily life, that is a good reason to seek a fuller assessment.

Your Evidence Edit moment:

Online mental health content can make your symptoms feel suddenly clear — but clarity is not the same as diagnosis. [E1][E2][E3]
A screening tool is designed to flag possible concerns, not confirm a diagnosis. [E2][E3][E4][E5]
The strongest evidence suggests some questionnaires can support early recognition, while social media content varies widely in quality and reliability. [E1][E2][E3][E4][E5]
Researchers also caution that expanding mental health labels too broadly may blur the line between disorder and normal human distress. [E6][E7]

A post can help something click — but it cannot see the full context of your life.

Some symptoms deserve attention, and some patterns need support. But understanding yourself and diagnosing yourself are not always the same process.

💭REFLECTION PROMPT

Something to reflect on…
When you hear mental health advice online, is it helping you understand your experience — or turning a complex feeling into a label too quickly?
And is it leaving room for context, uncertainty, and normal human variation?

📬OUTRO & CTA

If you found this useful, follow Beyond the Buzz and share it with a friend who likes a little science with their scroll.

You can also explore the full transcript, the clarity poll, and evidence in The Evidence Edit.

Until next time, stay curious — and stay kind to your mind.

This is Beyond the Buzz — cutting through the hype, because evidence is empowering.

Next week: Perimenopause symptoms, hormone testing, and clinical diagnosis

📊 POLL

📚REFERENCES — What’s the Hype (H1–H#) / What’s the Evidence (E1–E#)

🔓 Open Access |🔒Paywalled

H1

LifeStance Health. (2025, April 15). LifeStance Health. https://lifestance.com/insight/social-media-mental-health-impact-statistics-2025/

H2

Grand View Research. (2024). Grand View Research. https://www.grandviewresearch.com/industry-analysis/mental-health-apps-market-report

E1

Carter, A., Gracey, F., Moody, J., Ovens, A., & Chatburn, E. (2026). Quality, reliability and misinformation in mental health and neurodivergence content on social media: a systematic review. Journal of Social Media Research, 3(1), 30–47. https://doi.org/10.29329/jsomer.84 🔓

E2

Martin-Key, N. A., Spadaro, B., Funnell, E., Barker, E. J., Schei, T. S., Tomasik, J., & Bahn, S. (2022). The Current State and Validity of Digital Assessment Tools for Psychiatry: Systematic Review. JMIR Mental Health, 9(3), e32824. https://doi.org/10.2196/32824 🔓

E3

van Ballegooijen, W., Riper, H., Cuijpers, P., van Oppen, P., & Smit, J. H. (2016). Validation of online psychometric instruments for common mental health disorders: a systematic review. BMC Psychiatry, 16, 45. https://doi.org/10.1186/s12888-016-0735-7 🔓

E4

Negeri, Z. F., Levis, B., Sun, Y., He, C., Krishnan, A., Wu, Y., Bhandari, P. M., Neupane, D., Brehaut, E., Benedetti, A., Thombs, B. D., & Depression Screening Data (DEPRESSD) PHQ Group. (2021). Accuracy of the Patient Health Questionnaire-9 for screening to detect major depression: updated systematic review and individual participant data meta-analysis. BMJ, 375, n2183. https://doi.org/10.1136/bmj.n2183 🔓

E5

Plummer, F., Manea, L. E., Trepel, D., & McMillan, D. (2016). Screening for Anxiety Disorders with the GAD-7 and GAD-2: A Systematic Review and Diagnostic Meta-Analysis. General Hospital Psychiatry, 39, 24–31. https://doi.org/10.1016/j.genhosppsych.2015.11.005 🔒

E6

Thombs, B. D., Turner, K. A., & Shrier, I. (2019). Defining and Evaluating Overdiagnosis in Mental Health: A Meta-Research Review. Psychotherapy and Psychosomatics, 88(4), 193–202. https://doi.org/10.1159/000501647 🔒

E7

Bolton, D. (2013). Overdiagnosis Problems in the DSM-IV and the New DSM-5: Can They Be Resolved by the Distress–Impairment Criterion? The Canadian Journal of Psychiatry, 58(11), 612–617. https://doi.org/10.1177/070674371305801106 🔒

🎧 Prefer to listen?
Listen to Should You Diagnose Your Mental Health Online? on the Beyond the Buzz website — or follow Beyond the Buzz in your favourite podcast app.

Educational content only. This publication does not provide individualized medical, psychological, or professional advice.
Full disclaimer: beyondthebuzzmedia.com/disclaimer

This post includes the full transcript of this week’s Beyond the Buzz episode, followed by the clarity poll and full evidence.

🎧INTRO

Welcome to Beyond the Buzz — where curiosity meets clarity.
I’m Dr. Tara Moroz, scientist and communicator with decades of experience translating complex human research into clear, evidence-informed insight.

Today we’re looking at sunscreen use for sun protection, skin cancer prevention, vitamin D, and ingredient safety.

A lot of people are trying to balance sun protection with concerns about chemicals, ingredient safety, and vitamin D.
And mixed messaging online can leave people unsure what deserves attention.

Sometimes the loudest health debates hide the clearest answers.

Let’s take a closer look together — starting with what’s driving the buzz.

📊THE BUZZ

Sunscreen has become one of those health topics that seems to trigger strong reactions online.

Some posts frame sunscreen as essential daily protection. Others raise concerns about chemical ingredients, cancer risk, or vitamin D. And some people question whether sunscreen prevents skin cancer at all.

At the same time, sunscreen use is inconsistent in real life. In one U.S. survey, about half of respondents said they mainly used sunscreen during large amounts of sun exposure, while only 13.5% reported daily use. Eleven percent said they never used sunscreen at all. [H1]

And this is also a major commercial market. The global sun care products market was estimated at more than 12 billion U.S. dollars in 2024. [H2]

🧾RECEIPT CHECK

Let’s check the evidence — our kind of receipt check.

This is the moment to pause and ask the questions that matter — what’s the evidence, what’s the source, and how do we know?

🔬WHAT THE EVIDENCE SHOWS

Here’s what the evidence shows.

Public-health guidance supports sunscreen as one part of skin cancer prevention, especially when combined with other sun-protection behaviours like seeking shade, wearing protective clothing, and limiting intense sun exposure. [E1]

The strongest evidence supports sunscreen for reducing damage from ultraviolet radiation — UV radiation, the part of sunlight linked to skin aging and skin cancer. [E1][E2]

A systematic review and meta-analysis — a study that pulls together available research and combines results when possible — examined sunscreen use and melanoma and non-melanoma skin cancer risk. The findings were mixed overall, with researchers noting that sunscreen studies are difficult to interpret because sunscreen use is inconsistent and people who use sunscreen may also differ in their sun exposure and baseline skin-cancer risk. [E3]

One review — a paper that summarizes and interprets research on a topic — concluded that the best available evidence supports sunscreen as effective for preventing skin cancer when used properly and consistently. [E2]

But there are important nuances.

Most people do not apply sunscreen as heavily or as consistently as it is tested in research settings. [E2]

And sunscreen use is not a permission slip for unlimited sun exposure. Public-health guidance presents sunscreen as one layer of protection, not the only one. [E1][E2]

Vitamin D is another major concern in online discussions.

Another review found that typical sunscreen use does not usually lead to vitamin D deficiency in real-world conditions. [E4]

That may sound surprising, but researchers note that most people apply sunscreen imperfectly and still receive some UV exposure. [E4]

Ingredient safety is where the conversation becomes more complicated.

A randomized clinical trial — a study where researchers assign people to specific products or routines — found that several sunscreen active ingredients could be detected in the bloodstream after people applied sunscreen at high-use levels. [E5]

But detecting absorption is not the same as proving harm. [E5][E6]

The FDA has said more safety data are needed for some sunscreen ingredients commonly used in the United States, while also emphasizing that sunscreen remains an important public-health tool. [E6]

So the evidence does not support the idea that all sunscreen is unsafe. But it also supports continued safety research and regulatory review of ingredients. [E5][E6]

🧠WHY THIS BUZZ RESONATES

So why does this trend resonate?

Skin cancer prevention feels personally relevant to many people. Concerns about chemicals and ingredient safety can also feel emotionally immediate.

There is also a familiar tension here: people hear that sunlight helps with vitamin D, but they also hear that they should protect their skin from UV damage.

And online conversations often flatten complicated risk discussions into all-or-nothing claims.

A little nuance changes the picture.

🧭THE TAKEAWAY

So what’s the takeaway?

The strongest guidance and review evidence supports sunscreen as part of effective sun protection and skin cancer prevention. [E1][E2]

The evidence also suggests that common concerns online are more nuanced than many headlines imply, especially around vitamin D and ingredient absorption. [E4][E5][E6]

It can feel hard choosing between competing health warnings online.

Practically, that means using sunscreen as one layer of protection — alongside shade, clothing, hats, and avoiding the strongest sun when you can. [E1][E2]

Your Evidence Edit moment:

Sunscreen helps prevent skin cancer, but that does not mean every sunscreen question is settled.
This conversation is really about balancing proven protection against UV damage with ongoing questions about ingredient safety and regulation.
The strongest guidance and review evidence supports sunscreen as an effective part of sun protection, while current evidence on ingredient absorption supports continued research rather than proof of harm. [E1][E2][E5][E6]
Protection and uncertainty can exist together without cancelling each other out.

Clearer context often makes health decisions feel less overwhelming.

💭REFLECTION PROMPT

Something to reflect on…
How much of your opinion about sunscreen comes from evidence — and how much comes from repetition, headlines, or social media framing?

📬OUTRO & CTA

If you found this useful, follow Beyond the Buzz and share it with a friend who likes a little science with their scroll.

You can also explore the full transcript, the clarity poll, and evidence in The Evidence Edit.

Until next time, stay curious — and stay kind to your mind.

This is Beyond the Buzz — cutting through the hype, because evidence is empowering.

Next week: Should You Diagnose Your Mental Health Online?

📊 POLL

📚REFERENCES — What’s the Hype (H1–H#) / What’s the Evidence (E1–E#)

🔓 Open Access |🔒Paywalled

H1

Patlola, M., Shah, A.A., Stead, T., Mangal, R., & Ganti, L. (2023). Sunscreen use amongst US adults: a national survey. Arch Dermatol Res 315, 2137–2138. https://doi.org/10.1007/s00403-023-02603-8 🔒

H2

Grand View Research. (2024). Grand View Research. https://www.grandviewresearch.com/industry-analysis/sun-care-products-market-report

E1

US Preventive Services Task Force. (2018). Behavioral Counseling to Prevent Skin Cancer: US Preventive Services Task Force Recommendation Statement. JAMA, 319(11), 1134–1142. https://doi.org/10.1001/jama.2018.1623 🔓

E2

Sander, M., Sander, M., Burbidge, T., & Beecker, J. (2020). The efficacy and safety of sunscreen use for the prevention of skin cancer. CMAJ, 192(50), E1802-E1808. https://doi.org/10.1503/cmaj.201085 🔓

E3

Saes da Silva, E., Tavares, R., da Silva Paulitsch, F., & Zhang, L. (2018). Use of sunscreen and risk of melanoma and non-melanoma skin cancer: a systematic review and meta-analysis. European journal of dermatology : EJD, 28(2), 186–201. https://doi.org/10.1684/ejd.2018.3251 🔒

E4

Passeron, T., Bouillon, R., Callender, V., Cestari, T., Diepgen, T. L., Green, A. C., van der Pols, J. C., Bernard, B. A., Ly, F., Bernerd, F., Marrot, L., Nielsen, M., Verschoore, M., Jablonski, N. G., & Young, A. R. (2019). Sunscreen photoprotection and vitamin D status. British Journal of Dermatology, 181(5), 916-931. https://doi.org/10.1111/bjd.17992 🔓

E5

Matta, M. K., Florian, J., Zusterzeel, R., Pilli, N. R., Patel, V., Volpe, D. A., Yang, Y., Oh, L., Bashaw, E., Zineh, I., Sanabria, C., Kemp, S., Godfrey, A., Adah, S., Coelho, S., Wang, J., Furlong, L.-A., Ganley, C., Michele, T., & Strauss, D. G. (2020). Effect of Sunscreen Application on Plasma Concentration of Sunscreen Active Ingredients: A Randomized Clinical Trial. JAMA, 323(3), 256-267. https://doi.org/10.1001/jama.2019.20747 🔓

E6

U.S. Food and Drug Administration. (2021; current FDA Q&A page). Questions and Answers: FDA posts deemed final order and proposed order for over-the-counter sunscreen. U.S. Food and Drug Administration. https://www.fda.gov/drugs/understanding-over-counter-medicines/questions-and-answers-fda-posts-deemed-final-order-and-proposed-order-over-counter-sunscreen 🔓

🎧 Prefer to listen?
Listen to Is Sunscreen Safe — And Does It Work? on the Beyond the Buzz website — or follow Beyond the Buzz in your favourite podcast app.

Educational content only. This publication does not provide individualized medical, psychological, or professional advice.
Full disclaimer: beyondthebuzzmedia.com/disclaimer

This post includes the full transcript of this week’s Beyond the Buzz episode, followed by the clarity poll and full evidence.

🎧INTRO

Welcome to Beyond the Buzz — where curiosity meets clarity.

I’m Dr. Tara Moroz, scientist and communicator with decades of experience translating complex human research into clear, evidence-informed insight.

Today, we’re looking at ultra-processed foods and health — and the question people are really asking: are these foods seriously harmful, or is this just another food panic?

A simple label clue is this: if the ingredient list reads more like a formulation than a recipe, it may be ultra-processed. Think additives, flavour enhancers, colours, emulsifiers, sweeteners, or ingredients you would not normally cook with at home. Examples include soft drinks, packaged snacks, sweetened cereals, instant noodles, and many ready-to-heat meals.

The concern is clear. But the real question is what to do with that information in everyday life.

Let’s take a closer look together — starting with what’s driving the buzz.

📊THE BUZZ

Ultra-processed foods are not a fringe part of modern eating. In the United States, among people aged 1 year and older, the average share of calories from ultra-processed foods was 55.0% during August 2021 to August 2023. [H1]
Even after recent decreases among youth and adults, that is still a little more than half of total calories. [H1]

There is also a large commercial story here: one market forecast estimated that the ultra processed food market size would increase by over USD 850 billion between 2024 and 2029. [H2]

So the buzz is not coming from nowhere. Ultra-processed foods sit in the middle of daily eating patterns, health research, and a very large market.

That is why the topic travels so easily online. It touches what people eat, what companies sell, and what health headlines amplify.

🧾RECEIPT CHECK

Let’s check the evidence — our kind of receipt check.

This is the moment to pause and ask the questions that matter — what’s the evidence, what’s the source, and how do we know?

🔬WHAT THE EVIDENCE SHOWS

Here’s what the evidence shows.

The evidence supports taking the health concern seriously. Across major health reviews, higher exposure to ultra-processed foods is consistently associated with poorer health outcomes. [E1, E2]

That pattern also appears in prospective cohort studies, where researchers follow groups of people over time. Higher ultra-processed food consumption was associated with higher risk of diabetes, hypertension, obesity, and dyslipidemia — meaning unhealthy blood fat patterns such as high triglycerides or low HDL cholesterol. The authors found a consistent positive association, while also noting that risk estimates varied depending on how intake was measured. [E3]

The American Heart Association’s science advisory focuses on ultraprocessed foods and heart and metabolic health. Its key point is that higher consumption of ultraprocessed foods is associated with risks to heart and metabolic health, while better evidence is still needed on which foods, ingredients, and patterns matter most. [E4]

There is also evidence focused on all-cause mortality — meaning death from any cause during the study follow-up period. In that review, higher ultra-processed food consumption was associated with higher all-cause mortality risk. [E5]

So, when people ask, “Are ultra-processed foods really that bad?” the clearest evidence-based answer is: the concern is real. Higher intake is linked with worse health outcomes, including broad health outcomes, heart and metabolic health, and mortality risk. [E1, E4, E5]

The important nuance is about cause. Much of the evidence is observational, meaning it can show links between ultra-processed food intake and health outcomes, but it cannot prove that processing alone caused every outcome. [E2, E3, E5]

So the practical conclusion is not, “Ignore ultra-processed foods.” It is also not, “Fear every packaged food.” The better conclusion is to reduce ultra-processed foods as an overall pattern, especially when they become the default. [E1, E2, E4]

🧠WHY THIS BUZZ RESONATES

So why does this trend resonate?

Food is personal and shaped by real life. Ultra-processed foods show up in breakfast, snacks, school lunches, workdays, travel, tight budgets, busy evenings, and family routines.

People are not just asking, “What does the evidence say?” They are also asking, “What does this mean for the way I actually live?”

And that is where the online conversation can become unhelpful. One side can make the concern sound exaggerated. The other can make everyday eating feel like failure.

The evidence gives us a better way through: we can take the pattern seriously, without turning food into fear.

🧭THE TAKEAWAY

So what’s the takeaway?

The bottom line is clear: higher ultra-processed food exposure is linked with poorer health outcomes. [E1, E2] What is less certain is how much comes from the processing itself, the overall diet pattern, or other factors connected with food choices. [E2, E3, E5]

It makes sense to want clarity without food becoming fear.

Your Evidence Edit moment:

The evidence on ultra-processed foods is clearer than the online debate makes it sound. Higher intake is consistently linked with poorer health outcomes, including heart and metabolic health and mortality risk. [E1, E4, E5] Most of the evidence cannot prove processing alone is the cause, and some risk estimates vary depending on how intake is measured, but the pattern is consistent enough to take seriously. [E1, E2, E3, E5] The clearest answer is to reduce ultra-processed defaults, not fear every packaged food.

A practical place to start is not with a ban. It is to reduce how often ultra-processed foods become the default. That might mean swapping sweetened cereal for plain oats, soft drinks for water, packaged snack cakes for fruit and yogurt, or instant noodles for soup with vegetables, beans, eggs, or leftover chicken. The goal is not perfection. It is shifting the pattern over time.

💭REFLECTION PROMPT

Something to reflect on…
When you hear a claim about ultra-processed foods, is it helping you understand the pattern — or pushing you toward fear, guilt, or certainty too quickly?

📬OUTRO & CTA

If you found this useful, follow Beyond the Buzz and share it with a friend who likes a little science with their scroll.

You can also explore the full transcript, the clarity poll, and evidence in The Evidence Edit.

Until next time, stay curious — and stay kind to your mind.

This is Beyond the Buzz — cutting through the hype, because evidence is empowering.

Next week: Is Sunscreen Safe — And Does It Work?

📊 POLL

📚REFERENCES — What’s the Hype (H1–H#) / What’s the Evidence (E1–E#)

🔓 Open Access |🔒Paywalled

H1

Williams, A. M., Couch, C. A., Emmerich, S. E., & Ogburn, D. F. (2025). Ultra-processed food consumption among youth and adults: United States, August 2021–August 2023. NCHS Data Brief, 536, 1–11. https://dx.doi.org/10.15620/cdc/174612

H2

Technavio. (2025, January). Technavio. https://www.technavio.com/report/ultra-processed-food-market-industry-analysis

E1

Lane, M. M., Gamage, E., Du, S., Ashtree, D. N., McGuinness, A. J., Gauci, S., Baker, P., Lawrence, M., Rebholz, C. M., Srour, B., Touvier, M., Jacka, F. N., O’Neil, A., Segasby, T., & Marx, W. (2024). Ultra-processed food exposure and adverse health outcomes: umbrella review of epidemiological meta-analyses. BMJ, 384, e077310. https://doi.org/10.1136/bmj-2023-077310 🔓

E2

Dai, S., Wellens, J., Yang, N., Li, D., Wang, J., Wang, L., Yuan, S., He, Y., Song, P., Munger, R., Potvin Kent, M., MacFarlane, A. J., Mullie, P., Duthie, S., Little, J., Theodoratou, E., & Li, X. (2024). Ultra-processed foods and human health: An umbrella review and updated meta-analyses of observational evidence. Clinical Nutrition, 43(6), 1386-1394. https://doi.org/10.1016/j.clnu.2024.04.016 🔓

E3

Vitale, M., Costabile, G., Testa, R., D’Abbronzo, G., Nettore, I. C., Macchia, P. E., & Giacco, R. (2024). Ultra-Processed Foods and Human Health: A Systematic Review and Meta-Analysis of Prospective Cohort Studies. Advances in Nutrition, 15(1), 100121. https://doi.org/10.1016/j.advnut.2023.09.009 🔓

E4

Vadiveloo, M. K., Gardner, C. D., Bleich, S. N., Khandpur, N., Lichtenstein, A. H., Otten, J. J., Rebholz, C. M., Singleton, C. R., Vos, M. B., & Wang, S. (2025). Ultraprocessed Foods and Their Association With Cardiometabolic Health: Evidence, Gaps, and Opportunities: A Science Advisory From the American Heart Association. Circulation, 152(12), e245-e263. https://doi.org/10.1161/CIR.0000000000001365 🔓

E5

Liang, S., Zhou, Y., Zhang, Q., Yu, S., & Wu, S. (2025). Ultra-processed foods and risk of all-cause mortality: an updated systematic review and dose-response meta-analysis of prospective cohort studies. Systematic Reviews, 14(1), 53. https://doi.org/10.1186/s13643-025-02800-8 🔓

🎧 Prefer to listen?

Listen to Are Ultra-Processed Foods Bad for You? on the Beyond the Buzz website — or follow Beyond the Buzz in your favourite podcast app.

Educational content only. This publication does not provide individualized medical, psychological, or professional advice.
Full disclaimer: beyondthebuzzmedia.com/disclaimer

This post includes the full transcript of this week’s Beyond the Buzz episode, followed by the clarity poll and full evidence.

🎧INTRO

Welcome to Beyond the Buzz — where curiosity meets clarity.

I’m Dr. Tara Moroz, scientist and communicator with decades of experience translating complex human research into clear, evidence-informed insight.

If you’re new here, each week we explore body, mind, tech, and culture trends — especially when science and influence collide — to clarify what the strongest evidence actually supports.

And today is a bit different — stepping back after the first 24 to look at what actually holds up across them.

We’re surrounded by trends that sound scientific, feel persuasive, and spread quickly.

But something doesn’t quite add up.

Over the past 24 episodes, we’ve covered a wide range of health and wellness ideas.

Some promise precision — like genetic-based diets or continuous glucose monitoring (Episode 19 — DNA Diets; Episode 21 — CGM).
Others promise control — like digital detoxes, self-care strategies, or tracking your sleep and activity (Episode 11 — Digital Detox; Episode 12 — Self-Care & Burnout; Episode 2 — Sleep Trackers; Episode 10 — Wearables).

Some focus on biology — like the microbiome, cortisol, or GLP-1 medications (Episode 3 — Probiotics; Episode 15 — Cortisol; Episode 13 — GLP-1).
Others are shaped by culture and expectations — like influencer advice, money and wellbeing, or what’s considered “normal” in sexual health (Episode 16 — Influencer Advice; Episode 20 — Money & Happiness; Episode 24 — Sexual Activity).

And many sit right at the intersection — where visibility, marketing, and science overlap — like cold plunging, red-light therapy, detox cleanses, seed oils, and peptides (Episode 7 — Cold Plunging; Episode 8 — Red Light Therapy; Episode 18 — Detox Cleanses; Episode 22 — Seed Oils; Episode 23 — Peptides).

We’ve also looked at how information spreads — through AI-generated health content, mental health chatbots, and clinical research (Episode 5 — AI Health Content; Episode 6 — AI Mental Health; Episode 17 — Clinical Trials).

And across all of these — something interesting starts to show up.

Especially when something feels convincing before it’s fully supported.

Because in every episode, we’ve been asking one question:

Does this work?

But today, we’re asking something more useful.

What actually holds up — and what’s worth it?

📊THE SHIFT

Because when you look at any one trend on its own, it’s easy to get pulled into the details.

A study shows a benefit.
A headline makes a claim.
A story makes it feel convincing.

But across episodes, a different pattern starts to show up.

Most things don’t fall into “works” or “doesn’t work.”

They fall somewhere in between.

And the question shifts from:

Does this work?

to:

Is this worth it — for most people, most of the time?

🔬WHAT ACTUALLY HOLDS UP

When you step back, a few patterns show up again and again.

First — most trends contain some signal, but effects are usually small

Genetic-based diets lead to small, inconsistent changes (Episode 19 — DNA Diets).
Wearables can increase awareness or activity, but the effects are often modest and don’t last (Episode 10 — Wearables).
Digital detoxes can help — but effects are usually small and depend heavily on how changes are applied and sustained (Episode 11 — Digital Detox).

And with peptides, aside from collagen, most are not well studied in humans, are often unregulated, and may carry unknown risks (Episode 23 — Peptides).
Even with collagen, evidence suggests small, specific benefits under specific conditions — not broad or transformative effects (Episode 23 — Peptides).

Large, consistent effects are uncommon.

Second — more data doesn’t reliably change outcomes

Glucose monitoring can give detailed insight — but hasn’t been shown to consistently improve long-term outcomes in people without diabetes (Episode 21 — CGM).

Wearables can track more — but behavior change is often short-term (Episode 10 — Wearables).

Sleep tracking can increase awareness — but doesn’t consistently improve sleep, and for some people can increase anxiety about sleep (Episode 2 — Sleep Trackers).

More information can help you see more.

It doesn’t reliably change what happens next.

Third — context matters as much as, or more than, the tool

Self-care can support wellbeing — but it’s unlikely to resolve burnout without changes in workload, control, or environment (Episode 12 — Self-Care & Burnout).

Digital detoxes depend on what they replace and whether changes are realistic and sustainable (Episode 11 — Digital Detox).

And when it comes to deciding whether to participate in clinical trials, people don’t decide based on evidence alone — they weigh trust, clear information, practical demands, potential personal benefit, and contributing to science or future patients (Episode 17 — Clinical Trials).

The same approach can lead to very different outcomes depending on the context around it.

Fourth — simple rules are often more confident than the evidence

Detox cleanses sound compelling — but the body already has effective systems for processing and eliminating toxins, and there’s little evidence that commercial products enhance these processes in healthy people (Episode 18 — Detox Cleanses).

Sexual frequency is often treated as a measure of whether a sex life is normal — but satisfaction depends more on alignment and expectations than a specific number (Episode 24 — Sexual Activity).

And seed oils are often portrayed as harmful — but replacing saturated fats with unsaturated fats, including those commonly referred to as seed oils, is consistently associated with improved cardiovascular outcomes (Episode 22 — Seed Oils).

Simple rules feel clear.

But they often leave out what matters most.

Fifth — some effects are real, but often misunderstood

Placebo effects are real — but they tend to be modest for biological outcomes, and larger and more consistent for self-reported symptoms like pain or wellbeing (Episode 14 — Placebo Effects).

GLP-1 medications have meaningful effects during use — but weight regain is common after stopping, reflecting both underlying biology and the challenge of sustaining behavior change over time (Episode 13 — GLP-1).

Cortisol matters — but strong weight effects are seen in rare conditions with chronically high cortisol, not typical everyday stress (Episode 15 — Cortisol).

Real effects don’t always mean the outcome people expect.

Sixth — the biggest benefits are often the least visible

Daily movement, especially increasing activity from lower levels, shows consistent and meaningful health benefits (Episode 9 — Daily Steps).

Basic behaviors, done consistently over time, show up again and again.

But they’re rarely what gets attention.

And finally — sometimes the pattern is how we think, not just what we do

We’re drawn to certainty — even when the evidence is mixed (Episode 1 — Certainty in Health).

AI-generated health information can sound confident regardless of accuracy (Episode 5 — AI Health Content).

And influencer advice often reflects what is visible and relatable — not necessarily what is most supported by evidence (Episode 16 — Influencer Advice).

What feels convincing isn’t always what holds up.

🧠WHAT THIS MEANS

Across body, mind, tech, and culture trends, the same pattern holds.

Most ideas aren’t entirely right or wrong.

They sit somewhere in between.

With effects that are real — but often small, variable, and dependent on context.

But the way they’re presented often suggests something stronger, simpler, or more certain.

That gap is where confusion starts.

🧭THE TAKEAWAY

So what’s the takeaway?

Most trends aren’t wrong — they’re just not worth it.

Most trends contain some signal.

But very few are worth significant time, money, or attention
for most people.

Some provide insight.
Some help in specific situations.
Some are still evolving.

But very few deliver large, consistent, real-world impact.

Strong claims are easy to find.
Strong evidence is harder.

So the question isn’t just:

Does this work?

It’s:

Is this actually worth it — for me?

Because clarity doesn’t come from chasing every new idea.

It comes from understanding what actually holds up.

💭REFLECTION PROMPT

Something to reflect on…
When something sounds compelling,
are you responding to the evidence — or the way it’s presented?

📬OUTRO & CTA

If this episode helped you think differently about trends, follow Beyond the Buzz.

Each week, we take one body, mind, tech, or culture trend and look at what the evidence actually shows — what holds up, what doesn’t, and why the trend resonates.

You can explore the full transcript, the clarity poll, and the episode links in The Evidence Edit.

Until next time, stay curious — and stay kind to your mind.

This is Beyond the Buzz — cutting through the hype, because evidence is empowering.

Next week: Are Ultra-Processed Foods Bad for You?

📊 POLL

📚Previous Beyond the Buzz Episodes Referenced

1. How the Need for Certainty Shapes Health Decisions

2. How Sleep Trackers Shape What We Think About Sleep

3. What Probiotics Really Do for Gut Health

4. Do Daily Supplements Actually Increase Energy?

5. AI Health Answers and the Risk of Misinformation

6. AI Chatbots and Mental Health Support

7. Cold Plunging and Claims About Improving Mood

8. Red-Light Therapy and Exercise Recovery Claims

9. Do Daily Step Counts Really Matter?

10. Wearables

11. Digital Detoxes and Screen-Time Reduction: What the Evidence Shows

12. Self-Care and Burnout: What Actually Helps?

13. GLP-1 Medications and Weight Regain After Stopping

14. Placebo Effects in Wellness Practices Explained

15. Cortisol, Stress, and Weight Gain Claims

16. Influencer Health Advice and the Meaning of Authenticity

17. How Do People Decide to Join Clinical Trials?

18. Do Detox Cleanses Actually Help Your Body?

19. Can DNA Tests Really Personalize Your Diet?

20. How Much Does Money Really Affect Happiness?

21. Should You Use CGM Without Diabetes?

22. Should You Avoid Seed Oils?

23. Are Peptides Worth It for Muscle and Aging?

24. Is Your Sex Life Normal?

🎧 Prefer to listen?
Listen to Are Wellness Trends Worth Your Time and Money? on the Beyond the Buzz website — or follow Beyond the Buzz in your favourite podcast app.

Educational content only. This publication does not provide individualized medical, psychological, or professional advice.
Full disclaimer: beyondthebuzzmedia.com/disclaimer

This post includes the full transcript of this week’s Beyond the Buzz episode, followed by the clarity poll and full evidence.

🎧INTRO

Welcome to Beyond the Buzz — where curiosity meets clarity.
I’m Dr. Tara Moroz, scientist and communicator with decades of experience translating complex human research into clear, evidence-informed insight.

Today we’re looking at how sexual activity, desire, satisfaction, and dysfunction change across adulthood — and what it really means when a bedroom feels “dead.”

Many people quietly wonder if their sex life is normal at their age or life stage.
Mixed messages online can make it hard to answer that question — and can lead to confusion, self-doubt, or a loss of confidence.

It can feel like everyone else is doing something different with their sex life — or doing it better.

Let’s take a closer look together — starting with what’s driving the buzz.

📊THE BUZZ

Across social media and everyday conversations, you’ll see very different messages — from “dead bedroom” stories to expectations of constant, high-performing sex.

On one side, the idea of a “dead bedroom” is often tied to how often people think they should be having sex — and to the belief that desire naturally fades over time in long-term relationships.
In contrast, other messages suggest that sex should be frequent, intense, and consistently satisfying.

One widely cited statistic suggests that by 2024, only 37 percent of U.S. adults aged 18 to 64 reported having sex weekly (H1).
That means most people are having sex less than once a week.

So if you’re having sex once a week, you’re already above what most people report — and if it’s less frequent than that, it’s far from unusual.

Meanwhile, global data show that 59 percent of adults across 30 countries say they are happy with their romantic or sex life (H2) — which also means a substantial number of people are not.

But lower frequency and satisfaction can exist at the same time — and that’s not unusual.
This can make it hard to know what’s actually normal — or when something might be a problem.

🧾RECEIPT CHECK

Let’s check the evidence — our kind of receipt check.

This is the moment to pause and ask the questions that matter — what’s the evidence, what’s the source, and how do we know?

🔬WHAT THE EVIDENCE SHOWS

Here’s what the evidence shows.

This episode is focused on general patterns across populations — not on diagnosing or managing specific medical conditions like erectile dysfunction or conditions affecting sexual desire or arousal.

Large population studies show that sexual activity has declined over time — over roughly the past two decades, especially among adults aged 18 to 44 (E1).
People are having sex less often and reporting fewer partners (E1).

Research on long-term relationships shows that maintaining sexual desire is complex (E2).
A systematic review — a study that reviews all available research on a topic — found that desire can change with factors like novelty, emotional connection, and stress (E2).

Studies also show that sexual satisfaction can shift over the course of a relationship (E3).
Some people report declines over time, while others maintain or improve satisfaction depending on communication and expectations (E3).

When it comes to sexual dysfunction — ongoing problems with desire, arousal, or satisfaction — estimates vary widely.
A meta-analysis — a study that combines results from multiple studies — found that how common sexual dysfunction appears depends heavily on how it’s defined and measured (E4).

And importantly, sexual activity does not stop in older adulthood (E5).
A systematic review found that many older adults remain sexually active, though patterns may change with health, partners, and life context (E5).

Across studies spanning younger adults through older adulthood, there is a wide range of what people report — from low to high desire and activity (E1)(E2)(E5).

What the research does not define clearly is a specific cutoff where lower frequency becomes a problem — that depends more on distress or mismatch than on a number alone (E4).

But importantly, less-than-weekly sex is common, while many people still report being satisfied with their romantic or sex life (H1)(H2).

🧠WHY THIS TREND RESONATES

So why do so many people find themselves asking if their sex life is normal?

Part of it is expectation.
People often assume there is a “normal” frequency tied to age or relationship length.

Part of it is visibility.
Social media often makes it easier to see more extreme experiences than the wide middle range that most people report.

And part of it comes down to comparison — something that’s all too easy when certain versions of sex are presented as normal across social media and pornography, rather than reflecting the wide range of real-life experiences.

When frequency drops — which happens in many relationships — it can feel like something is wrong, even when it reflects common patterns (E1)(E3).

Importantly, satisfaction does not always track with frequency.
People may have less sex but still feel content in their relationship (H2).

That gap between expectation and reality is where uncertainty grows — and where many people start to question whether their own experience is normal.

🧭THE TAKEAWAY

So what’s the takeaway?

Most adults are not having sex weekly, and many are still satisfied — so lower frequency alone doesn’t define a “dead” bedroom (H1)(H2).
That includes people having sex less than weekly — with a wide range of what that looks like in practice.

At the same time, a substantial number of people are not satisfied — and that matters (H2).
What the evidence consistently shows is that there’s a wide range of what people experience — across age and relationships — and there’s no single pattern that defines what it should look like for any one couple (E1)(E2)(E3)(E5).

It can be hard to tell whether change signals a problem or not.

But change doesn’t mean you have to settle. A satisfying sex life isn’t limited to a certain age or stage — and it’s reasonable to want that, even if it looks different over time.

And broader trends — like rising spending on sexual wellness products — suggest that many people are still interested in improving their sexual experiences (H3).

A bedroom tends to feel “dead” — not because of a specific number, but when there’s a persistent mismatch in desire or when one or both partners feel distressed by the change.

A more useful starting point is to look at whether both partners feel satisfied and aligned — not just how often sex is happening.

Your Evidence Edit moment:
A “dead bedroom” isn’t defined by how often you have sex.
Many adults have sex less than once a week (H1) — and many still report being satisfied with their sex life (H2).
But a substantial number of people are not satisfied — and that matters (H2).
Across adulthood, there’s a wide range of desire and activity — including in long-term relationships and older age (E2)(E3)(E5).
Even how sexual dysfunction is defined varies, which makes simple cutoffs unreliable (E4).
The evidence is consistent on one point — frequency alone does not define satisfaction or relationship quality (H2)(E4).
A bedroom tends to feel “dead” not because of a specific number, but because of how satisfied people feel with their sex life — not just how often sex happens (H2)(E4).
A quiet bedroom isn’t always a broken one.

And that distinction can change how you interpret your own experience.

💭REFLECTION PROMPT

Something to reflect on…
When you think about your own expectations, are they based on a number — or on whether your experience feels fulfilling to you?

📬OUTRO & CTA

If you found this useful, follow Beyond the Buzz and share it with a friend who likes a little science with their scroll.
You can also explore the full transcript, the clarity poll, and evidence in The Evidence Edit.

Until next time, stay curious — and stay kind to your mind.

This is Beyond the Buzz — cutting through the hype, because evidence is empowering.

Next week: What have the first 24 episodes of Beyond the Buzz revealed?

📊 POLL

📚REFERENCES — What’s the Hype (H1–H#) / What’s the Evidence (E1–E#)

🔓 Open Access |🔒Paywalled

H1

The Sex Recession: The Share of Americans Having Regular Sex Keeps Dropping. (2024). The Sex Recession: The Share of Americans Having Regular Sex Keeps Dropping. https://ifstudies.org/blog/the-sex-recession-the-share-of-americans-having-regular-sex-keeps-dropping

H2

Ipsos Love Life Satisfaction 2025. (2025). Ipsos Love Life Satisfaction 2025. https://www.ipsos.com/sites/default/files/ct/news/documents/2025-02/Ipsos%20-%20Love%20Life%20Satisfaction%202025.pdf

H3

Sex Toys Market Size, Share & Growth Analysis Report, 2030. (2024). Sex Toys Market Size, Share & Growth Analysis Report, 2030. https://www.grandviewresearch.com/industry-analysis/sex-toys-market

E1

Ueda, P., Mercer, C. H., Ghaznavi, C., & Herbenick, D. (2020). Trends in Frequency of Sexual Activity and Number of Sexual Partners Among Adults Aged 18 to 44 Years in the US, 2000-2018. JAMA Network Open, 3(6), e203833. https://doi.org/10.1001/jamanetworkopen.2020.3833 🔓

E2

Mark, K. P., & Lasslo, J. A. (2018). Maintaining Sexual Desire in Long-Term Relationships: A Systematic Review and Conceptual Model. The Journal of Sex Research, 55(4-5), 563-581. https://doi.org/10.1080/00224499.2018.1437592 🔒

E3

Schmiedeberg, C., & Schröder, J. (2016). Does Sexual Satisfaction Change With Relationship Duration? Archives of Sexual Behavior, 45(1), 99-107. https://doi.org/10.1007/s10508-015-0587-0 🔒

E4

Ramírez-Santos, J., Cristóbal-Cañadas, D., Parron-Carreño, T., Lozano-Paniagua, D., & Nievas-Soriano, B. J. (2024). The problem of calculating the prevalence of sexual dysfunction: a meta-analysis attending gender. Sexual Medicine Reviews, 12(2), 116-126. https://doi.org/10.1093/sxmrev/qead058 🔒

E5

Cameron, J., & Santos-Iglesias, P. (2024). Sexual Activity of Older Adults: A Systematic Review of the Literature. International Journal of Sexual Health, 36(2), 145-166. https://doi.org/10.1080/19317611.2024.2318388 🔓

🎧 Prefer to listen?
Listen to Is Your Sex Life Normal? Sex, Desire, Satisfaction, and Dead Bedrooms on the Beyond the Buzz website — or follow Beyond the Buzz in your favourite podcast app.

Educational content only. This publication does not provide individualized medical, psychological, or professional advice.
Full disclaimer: beyondthebuzzmedia.com/disclaimer

This post includes the full transcript of this week’s Beyond the Buzz episode, followed by the clarity poll and full evidence.

🎧INTRO

Welcome to Beyond the Buzz — where curiosity meets clarity.
I’m Dr. Tara Moroz, scientist and communicator with decades of experience translating complex human research into clear, evidence-informed insight.

Today we’re looking at peptides — often promoted for muscle growth, anti-aging, and recovery after exercise.
You’re seeing them across social media and in conversations about performance and longevity, often framed as a shortcut to better health or performance - things like strength or endurance.
But when messaging is mixed, it can be hard to tell what actually holds up — and what’s just momentum.
When the promises sound simple, the evidence is often more limited.

Let’s take a closer look together — starting with what’s driving the buzz.

📊THE BUZZ

Peptides are gaining visibility across social media and online health spaces. (H1)
On TikTok alone, the hashtag #peptide shows over 300,000 posts, reflecting growing visibility and engagement. (H1)

At the same time, there’s a rapidly expanding commercial landscape around peptide use. (H2)
The global peptide therapeutics market is valued at over $130 billion USD and projected to more than double by 2034. (H2)

And alongside this growth, there are signals of rising demand beyond regulated use. (H3)
Labs are now conducting around 60,000 tests annually, reflecting growing demand for unregulated substances. (H3)

So this isn’t just a niche trend — it’s a large, visible, and evolving space.

At a basic level, peptides are short chains of amino acids — the building blocks of proteins — and some are already used in medicine.

But the ones showing up in these conversations don’t always look the same. Some are prescribed medications, like semaglutide or liraglutide used for weight loss, others are sold as supplements, like collagen peptides, and some are marketed online in less regulated ways.

A lot of the curiosity shows up in very practical questions — how they’re taken, where they come from, and what they’re actually supposed to do.

🧾RECEIPT CHECK

Let’s check the evidence — our kind of receipt check.

This is the moment to pause and ask the questions that matter — what’s the evidence, what’s the source, and how do we know?

🔬WHAT THE EVIDENCE SHOWS

Here’s what the evidence shows.

For muscle strength and recovery after exercise, much of the available research focuses on collagen peptides — the most studied in this area, but not representative of all peptides promoted online.
Collagen peptides are small protein fragments that may support connective tissue in the body. (E1)(E2)

Systematic reviews — studies that combine results from many trials — suggest that when collagen peptides are paired with long-term training, there may be modest improvements in strength and recovery outcomes. (E1)(E2)

But these effects are generally small and often depend on consistent exercise alongside supplementation. (E1)(E2)

For anti-aging claims, especially related to the skin, there is some evidence that oral collagen may improve skin elasticity and hydration. (E3)
These findings come from pooled studies, but results vary and tend to be modest rather than transformative. (E3)

In practical terms, that means changes can be measurable — but they’re unlikely to match the kinds of dramatic outcomes often described online.

When we move beyond collagen to other peptides — particularly those marketed for anti-aging or performance — the evidence becomes much less clear.
This includes many peptides people are asking about online, where high-quality human evidence is often limited or missing.

A major scientific statement on hormones and aging highlights that many interventions affecting hormone systems — including some peptides — show inconsistent benefits and may carry risks. (E4)

In studies of growth hormone — sometimes linked to peptide use — results show limited functional benefit in healthy older adults, along with increased adverse effects. (E5)

So while some peptide uses have targeted evidence for specific outcomes, broader claims about anti-aging or improved exercise performance are not consistently supported across high-quality evidence.

🧠WHY THIS TREND RESONATES

So why does this trend resonate?

This is part of a bigger shift toward personalized health.

Peptides feel targeted, scientific, and aligned with the idea of fine-tuning the body.

They also fit into the idea that aging, recovery, and performance can be controlled if you find the right tool.

And when people are already investing time in fitness or health routines, the idea of an added edge can be compelling.

🧭THE TAKEAWAY

So what’s the takeaway?

Here’s what holds up: some peptide uses — like collagen for skin or joint support — have modest, context-specific evidence. (E1)(E2)(E3)
What we don’t know is whether broader claims about muscle growth, anti-aging, or recovery translate into meaningful, consistent benefits in healthy people, and some approaches may involve risk. (E4)(E5)

It’s easy to feel confident — even when the evidence is still limited.

Your Evidence Edit moment:
Peptides aren’t broadly supported for muscle strength, aging, or improved exercise performance.
This conversation is about peptides promoted for muscle growth, anti-aging, and recovery after exercise — particularly in otherwise healthy people.
The evidence shows that some specific uses, like collagen, have modest, targeted benefits — but evidence for broader claims remains limited or inconsistent, with some potential risks.
Most research focuses on narrow outcomes or specific populations — not broad real-world use.
Strong claims about improved exercise performance or anti-aging often go beyond what high-quality evidence can support.
Narrow benefits are supported — broad promises are not.

If you’re considering peptides, start by asking what specific outcome you’re targeting — and whether there’s clear evidence for that exact use.

💭REFLECTION PROMPT

Something to reflect on…
When something feels highly targeted and scientific, what makes it easier to trust — and what helps you step back and ask what actually holds up?

📬OUTRO & CTA

If you found this useful, follow Beyond the Buzz and share it with a friend who likes a little science with their scroll.
You can also explore the full transcript, the clarity poll, and evidence in The Evidence Edit.

Until next time, stay curious — and stay kind to your mind.

This is Beyond the Buzz — cutting through the hype, because evidence is empowering.

Next week: What’s normal for sex across your life?

📊 POLL

📚REFERENCES — What’s the Hype (H1–H#) / What’s the Evidence (E1–E#)

🔓 Open Access |🔒Paywalled

H1

TikTok. (n.d.). Creative Center — #peptide Trending Hashtag on TikTok, see #peptide analytics. TikTok.
Metric value at reporting, from
• Hashtag: https://ads.tiktok.com/business/creativecenter/hashtag/peptide/pc/en?countryCode=US&period=7 (Value at reporting: 303K Overall; observed April 11, 2026)

Note: Platform engagement metrics are dynamic, real-time cumulative values and change over time.

H2

Fortune Business Insights. (2026). Peptide Therapeutics Market Size, Industry Share, Forecast, 2034. Fortune Business Insights. https://www.fortunebusinessinsights.com/industry-reports/peptide-therapeutics-market-101420

H3

The Guardian. (2026). “’Traceability is vital’: labs test thousands of unregulated substances amid peptide craze”. The Guardian. https://www.theguardian.com/science/2026/apr/06/labs-testing-thousands-of-unregulated-substances-amid-peptide-craze

E1

Bischof, K., Moitzi, A. M., Stafilidis, S., & König, D. (2024). Impact of Collagen Peptide Supplementation in Combination with Long-Term Physical Training on Strength, Musculotendinous Remodeling, Functional Recovery, and Body Composition in Healthy Adults: A Systematic Review with Meta-analysis. Sports Medicine, 54(11), 2865–2888. https://doi.org/10.1007/s40279-024-02079-0 🔒

E2

Khatri, M., Naughton, R. J., Clifford, T., & Harper, L. D. (2021). The effects of collagen peptide supplementation on body composition, collagen synthesis, and recovery from joint injury and exercise: a systematic review. Amino Acids, 53(11), 1493–1506. https://doi.org/10.1007/s00726-021-03072-x 🔒

E3

Pu, S.-Y., Huang, Y.-L., Pu, C.-M., Kang, Y.-N., Hoang, K. D., Chen, K.-H., & Chen, C. (2023). Effects of Oral Collagen for Skin Anti-Aging: A Systematic Review and Meta-Analysis. Nutrients, 15(9), 2080. https://doi.org/10.3390/nu15092080 🔓

E4

Cappola, A. R., Auchus, R. J., El-Hajj Fuleihan, G., Handelsman, D. J., Kalyani, R. R., McClung, M. R., Stuenkel, C. A., Thorner, M. O., & Verbalis, J. G. (2023). Hormones and Aging: An Endocrine Society Scientific Statement. The Journal of Clinical Endocrinology & Metabolism, 108(8), 1835–1874. https://doi.org/10.1210/clinem/dgad225 🔓

E5

Liu, H., Bravata, D. M., Olkin, I., Nayak, S., Roberts, B., Garber, A. M., & Hoffman, A. R. (2007). Systematic Review: The Safety and Efficacy of Growth Hormone in the Healthy Elderly. Annals of Internal Medicine, 146(2), 104–115. https://doi.org/10.7326/0003-4819-146-2-200701160-00005 🔒

🎧 Prefer to listen?
Listen to Are Peptides Worth It for Muscle, Anti-Aging, and Recovery? on the Beyond the Buzz website — or follow Beyond the Buzz in your favourite podcast app.

Educational content only. This publication does not provide individualized medical, psychological, or professional advice.
Full disclaimer: beyondthebuzzmedia.com/disclaimer

This post includes the full transcript of this week’s Beyond the Buzz episode, followed by the clarity poll and full evidence.

🎧INTRO

Welcome to Beyond the Buzz — where curiosity meets clarity.
I’m Dr. Tara Moroz, scientist and communicator with decades of experience translating complex human research into clear, evidence-informed insight.

Today we’re looking at seed oils and health — a topic that’s gained a lot of attention, often framed as something to avoid or eliminate.
You’re likely hearing mixed messages in everyday conversations, online, and even in food choices.
When advice conflicts, it can take time and energy to sort through what matters.
Simple rules can feel convincing — even when the evidence doesn’t fully support them.

Let’s take a closer look together — starting with what’s driving the buzz.

📊THE BUZZ

Seed oils — like soybean, corn, sunflower, and canola oils used in cooking and packaged foods — are often discussed as harmful, especially online.
They’re often described as inflammatory or linked to chronic disease, with advice to avoid them entirely.

This is not a small or niche topic.
A recent survey found that 28% of people report actively avoiding seed oils — roughly 1 in 4 of us. (H1)
That’s a sizable portion of people actively changing their food choices.

There’s also a large and growing industry behind these products.
The Vegetable Oil Market was valued at almost 400 billion USD in 2025, and is expected to reach over 420 billion USD in 2026. (H2)

So what we’re seeing is strong opinions, widespread behavior change, and a major global market.

🧾RECEIPT CHECK

Let’s check the evidence — our kind of receipt check.

This is the moment to pause and ask the questions that matter — what’s the evidence, what’s the source, and how do we know?

🔬WHAT THE EVIDENCE SHOWS

Here’s what the evidence shows.

First, it helps to define a key term — systematic review.
A systematic review is a study that reviews all available research on a topic.

Across multiple systematic reviews and meta-analyses, the evidence does not support the claim that seed oils are broadly harmful. (E1)

In fact, when looking at linoleic acid — a type of omega-6 fat commonly found in seed oils — higher intake has been associated with a lower risk of coronary heart disease in long-term observational studies. (E2)

Linoleic acid intake has also been linked to lower overall mortality in pooled analyses of population studies. (E3)

When researchers compare different fats, replacing saturated fats — typically solid fats like butter — with unsaturated fats from vegetable oils tends to improve blood lipid profiles, including lowering LDL cholesterol. (E4)

LDL cholesterol — often called “bad cholesterol” — is linked to heart disease risk.

Another common concern is inflammation.
But controlled trials summarized in systematic reviews do not show that higher linoleic acid intake increases markers of inflammation in healthy people. (E5)

At a broader level, umbrella reviews — which synthesize multiple systematic reviews — show that different edible oils have varying effects, but do not support the idea that all seed oils are harmful — meaning consistently linked to higher risk of heart disease or death. (E1)

That said, most of this evidence comes from population studies and controlled trials in specific contexts — not every real-world scenario.
Diet patterns, food processing, and overall lifestyle all play a role, and no single ingredient explains health outcomes on its own.

🧠WHY THIS TREND RESONATES

So why does this trend resonate?

One possible reason is that simple rules can feel easier to follow than complex evidence. “Cut this out” is often clearer than “it depends on context.”

There’s also a growing focus on food processing and ingredient lists, which may make seed oils an easy target.

And when people are trying to make healthier choices, clear boundaries can feel reassuring — even if the underlying evidence is more nuanced.

🧭THE TAKEAWAY

So what’s the takeaway?

Here’s what holds up: across multiple high-quality reviews, seed oils — particularly those high in linoleic acid — are not consistently linked to harm and are often associated with favorable cardiovascular markers when used in place of saturated fats. What we don’t know is how individual oils, processing, and overall diet patterns interact in real-world settings over time. (E1)(E2)(E3)(E4)(E5)

It’s easy to feel confident — even when the evidence doesn’t support it.

Your Evidence Edit moment:
Seed oils are not clearly harmful — and no specific seed oil has been consistently shown to cause harm in high-quality human studies, even though they’re often framed that way.
This conversation is really about how different types of dietary fats relate to long-term health outcomes.
Across systematic reviews and meta-analyses, the evidence does not show increased inflammation or harm from typical intake, and in some cases shows associations with improved cardiovascular markers when replacing saturated fats. (E1)(E2)(E3)(E4)(E5)
At the same time, most research looks at dietary patterns over time, not single foods in isolation.
Strong claims about eliminating one ingredient often go beyond what the evidence can support.
Clear rules feel simple — but evidence rarely is.

Evidence is clear that focusing on the overall pattern matters most — instead of eliminating seed oils, replace saturated fats like butter with unsaturated oils as part of a balanced diet.

💭REFLECTION PROMPT

Something to reflect on…
When you hear a clear rule about food — what helps you decide whether it reflects the full picture, or just part of it?

📬OUTRO & CTA

If you found this useful, follow Beyond the Buzz and share it with a friend who likes a little science with their scroll.
You can also explore the full transcript, the clarity poll, and evidence in The Evidence Edit.

Until next time, stay curious — and stay kind to your mind.

This is Beyond the Buzz — cutting through the hype, because evidence is empowering.

Next week: Do peptides work for performance and aging?

📊 POLL

📚REFERENCES — What’s the Hype (H1–H#) / What’s the Evidence (E1–E#)

🔓 Open Access |🔒Paywalled

H1

IFIC Spotlight Survey: Americans’ Perceptions Of Seed Oils. (2025). IFIC Spotlight Survey: Americans’ Perceptions Of Seed Oils. https://ific.org/wp-content/uploads/2025/04/IFIC-2025-Spotlight-Survey-Seed-Oils.pdf

H2

Mordor Intelligence. (2026). Vegetable Oil Market Size & Share Analysis. Mordor Intelligence. https://www.mordorintelligence.com/industry-reports/vegetable-oil-market

E1

Voon, P. T., Ng, C. M., Ng, Y. T., Wong, Y. J., Yap, S. Y., Leong, S. L., Yong, X. S., & Lee, S. W. H. (2024). Health Effects of Various Edible Vegetable Oil: An Umbrella Review. Advances in Nutrition, 15(9), 100276. https://doi.org/10.1016/j.advnut.2024.100276 🔓

E2

Farvid, M. S., Ding, M., Pan, A., Sun, Q., Chiuve, S. E., Steffen, L. M., Willett, W. C., & Hu, F. B. (2014). Dietary Linoleic Acid and Risk of Coronary Heart Disease: A Systematic Review and Meta-Analysis of Prospective Cohort Studies. Circulation, 130(18), 1568-1578. https://doi.org/10.1161/CIRCULATIONAHA.114.010236 🔓

E3

Li, J., Guasch-Ferré, M., Li, Y., & Hu, F. B. (2020). Dietary intake and biomarkers of linoleic acid and mortality: systematic review and meta-analysis of prospective cohort studies. The American Journal of Clinical Nutrition, 112(1), 150-167. https://doi.org/10.1093/ajcn/nqz349 🔓

E4

Schwingshackl, L., Bogensberger, B., Benčič, A., Knüppel, S., Boeing, H., & Hoffmann, G. (2018). Effects of oils and solid fats on blood lipids: a systematic review and network meta-analysis. Journal of Lipid Research, 59(9), 1771-1782. https://doi.org/10.1194/jlr.P085522 🔓

E5

Johnson, G. H., & Fritsche, K. (2012). Effect of Dietary Linoleic Acid on Markers of Inflammation in Healthy Persons: A Systematic Review of Randomized Controlled Trials. Journal of the Academy of Nutrition and Dietetics, 112(7), 1029-1041.e15. https://doi.org/10.1016/j.jand.2012.03.029 🔒

🎧 Prefer to listen?
Listen to Should You Avoid Seed Oils? Evidence on Seed Oils and Health on the Beyond the Buzz website — or follow Beyond the Buzz in your favourite podcast app.

Educational content only. This publication does not provide individualized medical, psychological, or professional advice.
Full disclaimer: beyondthebuzzmedia.com/disclaimer

This post includes the full transcript of this week’s Beyond the Buzz episode, followed by the clarity poll and full evidence.

🎧INTRO

Welcome to Beyond the Buzz — where curiosity meets clarity.
I’m Dr. Tara Moroz, scientist and communicator with decades of experience translating complex human research into clear, evidence-informed insight.

Today we’re looking at continuous glucose monitoring — or CGM — and whether it offers meaningful insight for metabolic health beyond diabetes. CGM is a wearable device that tracks glucose levels in real time through a small sensor under the skin.

Increasingly, people are using these devices to understand how food, exercise, and daily habits affect their bodies. It can feel like a way to gain control and clarity in a complex health landscape.

But with so many interpretations of glucose spikes, patterns, and “optimal” ranges online, it can be hard to know what actually holds up.
For some people, when more data feels empowering, it can also make everyday decisions about food and habits more complicated.

Let’s take a closer look together — starting with what’s driving the buzz.

📊THE BUZZ

Across social media and wellness spaces, CGM is showing up more frequently right now.

More than seven million people are using one CGM system globally, highlighting how widespread this technology has become (H1).

At the same time, the market is growing quickly. The global CGM device market was valued at over 13 billion US dollars in 2025 and is projected to exceed 41 billion dollars by 2033 (H2).

CGM has a primary role in diabetes management. But beyond that, a new narrative is starting to take hold.

CGMs are increasingly being used to “optimize” metabolism — using real-time glucose data to track how the body responds to food and personalize choices.

The idea is simple and compelling: if you can see how your body responds, you can make better decisions.

And that promise — personalized insight, immediate feedback — is a powerful one.

🧾RECEIPT CHECK

Let’s check the evidence — our kind of receipt check.

This is the moment to pause and ask the questions that matter — what’s the evidence, what’s the source, and how do we know?

🔬WHAT THE EVIDENCE SHOWS

Here’s what the evidence shows.

A systematic review — a study that combines all available research — looked at CGM use in people without diabetes (E1).

It found that while CGM can provide detailed glucose patterns, these insights have not been consistently shown to improve outcomes like body weight, blood sugar markers, or overall metabolic health in people without diabetes (E1).

And that distinction matters.

Another systematic review and meta-analysis of randomized controlled trials — a high-quality study design — examined whether CGM helps change behavior (E2).

It showed that CGM can support behavior change in some cases, particularly when combined with structured programs, but these effects are often short-term, variable, and not consistent across groups (E2).

A scoping review — a broad summary of existing research — found that CGM may increase awareness and engagement with health behaviors, but this does not always translate into sustained or meaningful change (E3).

Research also suggests that while CGM has potential applications in wellness and sports, its role in healthy individuals is not yet clearly defined (E4).

In the context of heart disease and related risk, a systematic review found that while CGM may help guide lifestyle decisions, the evidence supporting long-term benefits in people without diabetes remains limited (E5).

So overall, the evidence points to growing interest and potential — but also important uncertainty about long-term impact.

In people without diabetes, it’s still unclear how to interpret specific glucose changes or what they mean for long-term health (E1)(E2)(E5).

That also raises a common question — are glucose spikes in people without diabetes actually harmful?
Right now, it’s still unclear whether typical fluctuations within normal ranges in otherwise healthy individuals translate into long-term health risk (E1)(E5).

🧠WHY THIS TREND RESONATES

So why does this trend resonate?

There may be something deeper going on here.

If you’ve ever seen your own data change in real time, it’s easy to see why this catches attention.

CGM offers something many health tools don’t — immediate, personalized feedback.

For many people, that can feel more relevant and more actionable.

It also fits with a broader shift toward self-tracking and personalization in health and wellness (E4).

And for many people, seeing numbers change after a meal or workout can create a sense of cause and effect — even when the long-term meaning of those changes isn’t fully clear (E3).

Part of the appeal seems to be that combination — visibility, personalization, and control — which may help explain why this trend is gaining traction.

🧭THE TAKEAWAY

So what’s the takeaway?

Here’s what holds up: CGM can provide detailed glucose data and can support awareness or short-term behavior change in some people (E1)(E2). What we don’t have is consistent evidence that this leads to meaningful long-term health benefits in people without diabetes (E1)(E2)(E5).

It can feel empowering to see data, yet unclear what it really means.

If you don’t have diabetes and are using — or considering using — a CGM, it may be worth pausing to consider whether the data you see actually requires a change in your behavior (E1)(E5).

Your Evidence Edit moment:
In people without diabetes, tracking your glucose in real time has not been consistently shown to improve health outcomes.
Continuous glucose monitoring (CGM) is also used by people without diabetes to track how food and lifestyle affect their glucose.
The evidence shows that while CGM can increase awareness and sometimes support behavior change, the overall impact on long-term health outcomes in people without diabetes is mixed and still limited (E1)(E2)(E5).
More data can inform decisions, but it doesn’t guarantee better outcomes.

Seeing patterns is easy.

Interpreting them is the hard part.

💭REFLECTION PROMPT

Something to reflect on…
When you see health data about your body, what helps you decide whether it’s meaningful — or just interesting?

📬OUTRO & CTA

If you found this useful, follow Beyond the Buzz and share it with a friend who likes a little science with their scroll.
You can also explore the full transcript, the clarity poll, and evidence in The Evidence Edit.

Until next time, stay curious — and stay kind to your mind.

This is Beyond the Buzz — cutting through the hype, because evidence is empowering.

Next week: Seed Oils and Health

📊 POLL

📚REFERENCES — What’s the Hype (H1–H#) / What’s the Evidence (E1–E#)

🔓 Open Access |🔒Paywalled

H1

Abbott. (2026). Revolutionizing Diabetes Care to Make a Difference. Abbott. https://www.abbott.com/en-us/careers/working-with-us/changing-lives/revolutionizing-diabetes-care-to-make-a-difference

H2

Grand View Research. (2025). Continuous Glucose Monitoring Devices Market Report, 2033. Grand View Research. https://www.grandviewresearch.com/industry-analysis/continuous-glucose-monitoring-market

E1

Liao, X., Li, Y., Tang, S., Xiao, Y., Yu, X., Huang, R., & Zhong, T. (2026). Continuous glucose monitoring in non-diabetic populations: a systematic review of observational and interventional studies with meta-analysis. European Journal of Medical Research, 31(1), 397. https://doi.org/10.1186/s40001-026-03920-0 🔓

E2

Richardson, K. M., Jospe, M. R., Bohlen, L. C., Crawshaw, J., Saleh, A. A., & Schembre, S. M. (2024). The efficacy of using continuous glucose monitoring as a behaviour change tool in populations with and without diabetes: a systematic review and meta-analysis of randomised controlled trials. International Journal of Behavioral Nutrition and Physical Activity, 21(1), 145. https://doi.org/10.1186/s12966-024-01692-6 🔓

E3

Jospe, M. R., Richardson, K. M., Saleh, A. A., Bohlen, L. C., Crawshaw, J., Liao, Y., Konnyu, K., & Schembre, S. M. (2024). Leveraging continuous glucose monitoring as a catalyst for behaviour change: a scoping review. International Journal of Behavioral Nutrition and Physical Activity, 21, 74. https://doi.org/10.1186/s12966-024-01622-6 🔓

E4

Holzer, R., Bloch, W., & Brinkmann, C. (2022). Continuous Glucose Monitoring in Healthy Adults—Possible Applications in Health Care, Wellness, and Sports. Sensors, 22(5), 2030. https://doi.org/10.3390/s22052030 🔓

E5

Ahmed, N., Ali, M. F. E., Mohamed, M. N. H., & Rabih, M. R. M. (2025). Use of Continuous Glucose Monitoring in Non-diabetic Individuals for Cardiovascular Prevention: A Systematic Review of Its Impact on Guiding Lifestyle Interventions. Cureus, 17(10), e94460. https://doi.org/10.7759/cureus.94460 🔓

🎧 Prefer to listen?
Listen to Should You Use CGM Without Diabetes? on the Beyond the Buzz website — or follow Beyond the Buzz in your favourite podcast app.

Educational content only. This publication does not provide individualized medical, psychological, or professional advice.
Full disclaimer: beyondthebuzzmedia.com/disclaimer

This post includes the full transcript of this week’s Beyond the Buzz episode, followed by the clarity poll and full evidence.

🎧INTRO

Welcome to Beyond the Buzz — where curiosity meets clarity.
I’m Dr. Tara Moroz, scientist and communicator with decades of experience translating complex human research into clear, evidence-informed insight.

Today we’re looking at money, happiness, and wellbeing.

Many people are trying to figure out how much money really matters for a good life.
But mixed messages about income and happiness can leave people feeling unsure and frustrated.

It sounds simple — but the answer may not be.

Let’s take a closer look together — starting with what’s driving the buzz.

📊THE BUZZ

This question shows up everywhere — in conversations, headlines, and everyday decisions.

Globally, money is one of the most commonly cited reasons for unhappiness.
Among people who report being unhappy, 58% say their finances are the main cause (H1).

At the same time, there’s a massive industry built around improving wellbeing.
The global wellness market has reached almost $7 trillion, after years of steady growth (H2).

So on one side, we see financial stress as a major source of distress.
On the other, we see a rapidly expanding market promising better wellbeing.

And somewhere in between is the question many people are asking:
Does having more money actually make us happier?

🧾RECEIPT CHECK

Let’s check the evidence — our kind of receipt check.

This is the moment to pause and ask the questions that matter — what’s the evidence, what’s the source, and how do we know?

🔬WHAT THE EVIDENCE SHOWS

Here’s what the evidence shows.

First, changes in income do matter for mental health —but the effect is not always straightforward.
A systematic review — a study that combines results from many studies — found that increases in income are generally linked to improvements in mental health and wellbeing (E1).

Second, how people feel about their finances matters as much as income itself.
A meta-analysis — a statistical summary of multiple studies — shows that financial satisfaction is strongly linked to overall life satisfaction (E2).

This means it’s not just how much you earn — but how secure or satisfied you feel.

Third, inequality plays a role.
Higher income inequality within a society is associated with lower subjective wellbeing overall (E3).

So it’s not only individual income — it’s how your finances fit in with those around you. The broader context matters too.

Fourth, financial stress is consistently linked to poorer mental health.
A systematic review found that financial stress is associated with higher risk of depression in adults (E4).

And finally, when researchers look broadly at what increases happiness, money is one factor among many — not the defining one.
A review of experimental studies shows that many different factors influence happiness, including social connection and daily experiences (E5).
At the same time, one large study found that the feeling of wellbeing — how people feel day to day — tends to rise with income, even beyond earlier proposed thresholds (E6).

So overall, income does matter — but its impact depends on context, perception, and other life factors.

🧠WHY THIS TREND RESONATES

This connects to something many people feel every day.

Money is closely tied to basic needs, security, and future planning.
It affects housing, food, healthcare, and stability.

So when finances feel uncertain, the emotional impact can be immediate.

And as income rises, spending often rises too — which means financial pressure doesn’t always disappear at higher income levels.

At the same time, money is often used as a simple way to measure success.
It’s visible, comparable, and easy to track.

But wellbeing is more complex.
It includes emotional, social, and psychological factors that aren’t captured by income alone.

So it makes sense that people look for a clear number —
even if the reality is more layered.

🧭THE TAKEAWAY

So what’s the takeaway?

The evidence suggests that money does influence happiness, especially through reducing financial stress and supporting stability (E1)(E4).
But the relationship is not linear or complete — how people feel about their finances and broader life context also play a major role (E2)(E3)(E5).

It can feel like there should be a clear number to aim for, but the evidence does not support a single income number that determines happiness — and money alone doesn’t explain how people feel.

Your Evidence Edit moment:
There is strong evidence that more money is linked to higher wellbeing — but it doesn’t buy happiness on its own. Income can improve mental health and daily experience, especially by reducing financial stress, but it does not fully determine how people feel (E1)(E4)(E5). How satisfied people feel with their finances — and the broader social context they live in — also shapes wellbeing in meaningful ways (E2)(E3).
More money helps — but it’s not the whole story.

Reducing financial stress where possible is important, but daily experiences — like how you spend your time — and social connection also shape wellbeing.

💭REFLECTION PROMPT

Something to reflect on…
When you think about your own wellbeing, what feels most connected to it — income, financial security, or something else?

📬OUTRO & CTA

If you found this useful, follow Beyond the Buzz and share it with a friend who likes a little science with their scroll.
You can also explore the full transcript, the clarity poll, and evidence in The Evidence Edit.

Until next time, stay curious — and stay kind to your mind.

This is Beyond the Buzz — cutting through the hype, because evidence is empowering.

Next week: Is Continuous Glucose Monitoring Useful Without Diabetes?

📊 POLL

📚REFERENCES — What’s the Hype (H1–H#) / What’s the Evidence (E1–E#)

🔓 Open Access |🔒Paywalled

H1
Ipsos. (2025, March 18). Global attitudes to happiness and quality of life. Ipsos. https://www.ipsos.com/en/global-attitudes-to-happiness-and-quality-of-life 🔓

H2
Global Wellness Institute. (2025, November 19). The global wellness economy hits a record $6.8 trillion and is forecast to reach $9.8 trillion by 2029. Global Wellness Institute. https://globalwellnessinstitute.org/press-room/press-releases/the-global-wellness-economy-hits-a-record-6-8-trillion-and-is-forecast-to-reach-9-8-trillion-by-2029/ 🔓

E1
Thomson, R. M., Igelström, E., Purba, A. K., Shimonovich, M., Thomson, H., McCartney, G., Reeves, A., Leyland, A., Pearce, A., & Katikireddi, S. V. (2022). How do income changes impact on mental health and wellbeing for working-age adults? A systematic review and meta-analysis. The Lancet Public Health, 7(6), e515-e528. https://doi.org/10.1016/S2468-2667(22)00058-5 🔓

E2
Ngamaba, K. H., Armitage, C., Panagioti, M., & Hodkinson, A. (2020). How closely related are financial satisfaction and subjective well-being? Systematic review and meta-analysis. Journal of Behavioral and Experimental Economics, 85, 101522. https://doi.org/10.1016/j.socec.2020.101522 🔒

E3
Ngamaba, K. H., Panagioti, M., & Armitage, C. J. (2018). Income inequality and subjective well-being: a systematic review and meta-analysis. Quality of Life Research, 27(3), 577-596. https://doi.org/10.1007/s11136-017-1719-x 🔓

E4
Guan, N., Guariglia, A., Moore, P., Xu, F., & Al-Janabi, H. (2022). Financial stress and depression in adults: A systematic review. PLoS One, 17(2), e0264041. https://doi.org/10.1371/journal.pone.0264041 🔓

E5
Folk, D., & Dunn, E. (2024). How Can People Become Happier? A Systematic Review of Preregistered Experiments. Annual Review of Psychology, 75, 467-493. https://doi.org/10.1146/annurev-psych-022423-030818 🔓

E6
Killingsworth, M. A. (2021). Experienced well-being rises with income, even above $75,000 per year. Proceedings of the National Academy of Sciences, 118(4). https://doi.org/10.1073/pnas.2016976118 🔓

🎧 Prefer to listen?
Listen to How Much Money Affects Happiness and Wellbeing on the Beyond the Buzz website — or follow Beyond the Buzz in your favourite podcast app.

Educational content only. This publication does not provide individualized medical, psychological, or professional advice.
Full disclaimer: beyondthebuzzmedia.com/disclaimer

This post includes the full transcript of this week’s Beyond the Buzz episode, followed by the clarity poll and full evidence.

🎧INTRO

Welcome to Beyond the Buzz — where curiosity meets clarity.
I’m Dr. Tara Moroz, scientist and communicator with decades of experience translating complex human research into clear, evidence-informed insight.

Today we’re looking at direct-to-consumer genetic testing and personalized diet recommendations.

Many people are trying to make better food choices using new tools and information.
But mixed messages about genetics and nutrition can make it hard to know what actually helps.

It sounds promising — but does the science really match the marketing?

Let’s take a closer look together — starting with what’s driving the buzz.

📊THE BUZZ

This trend is everywhere right now.

Over 56 million people have their genetic information in major direct-to-consumer testing databases (H1) — roughly the population of a large country.

And it’s not just about curiosity anymore.

There’s a substantial market built around using that genetic data to guide food choices.
The global personalized nutrition market was valued at over 15 billion US dollars in 2025 (H2).

That includes diet plans, supplements, and apps that claim to tailor recommendations to your DNA.

The idea behind it is simple and appealing.
Your genes influence how your body responds to nutrients.
So if you know your genes, you can personalize your diet.

But that raises an important question.
How much can these tools actually deliver — and what does the evidence really show?

🧾RECEIPT CHECK

Let’s check the evidence — our kind of receipt check.

This is the moment to pause and ask the questions that matter — what’s the evidence, what’s the source, and how do we know?

🔬WHAT THE EVIDENCE SHOWS

Here’s what the evidence shows.

Several systematic reviews — studies that combine results from many studies — have looked at whether genotype-based advice changes health or behavior (E1).

Overall, the findings are mixed.
Some studies show small improvements in behavior, like modest changes in diet or physical activity (E1).
But these effects are often small and not consistent across studies (E1).

Another systematic review of randomized controlled trials — where people are randomly assigned to groups — found that personalized nutrition advice can improve dietary intake in some cases (E2).
But again, the effects are generally modest and vary between individuals (E2).

When we look specifically at direct-to-consumer genetic testing, the evidence suggests that receiving genetic results does not lead to large or lasting behavior changes for most people (E3).

There is also an important question about scientific validity — whether the genetic markers used are reliably linked to meaningful nutrition outcomes.
A review of evaluation frameworks found that many gene–diet relationships lack strong or consistent evidence (E4).

Professional guidance reflects this uncertainty.
A consensus report from the Academy of Nutrition and Dietetics notes that genetic testing may have a role in nutrition care, but it should be used carefully and alongside other clinical information (E5).

So while the concept is biologically plausible, the current evidence does not support strong or consistent benefits for most people.

In practical terms, these tests may offer some insight, but they’re unlikely to dramatically change health outcomes or provide a fully personalized diet on their own.

🧠WHY THIS TREND RESONATES

So why does this trend resonate?

It taps into something very human.

People want answers that feel specific and personal.
Generic advice like “eat well” can feel vague or hard to apply.

Genetic information offers a sense of precision.
It feels scientific, individualized, and actionable.

There’s also a sense of control.
If your DNA holds the key, it can feel like you’re unlocking a personalized roadmap.

And in a crowded nutrition space, personalization stands out.

🧭THE TAKEAWAY

So what’s the takeaway?

The evidence suggests that genotype-based nutrition advice can lead to small changes in behavior, but results are mixed and inconsistent (E1)(E2).
There is little evidence that direct-to-consumer genetic testing alone leads to meaningful or lasting behavior change (E3).
Many gene–diet links remain weakly established (E4).

It’s understandable to want answers that feel uniquely yours.

Your Evidence Edit moment:
DNA-based diet advice sounds precise — but the evidence is much less clear.
The evidence shows small effects at best — and results are inconsistent.
Current research shows small or variable changes in behavior (E1)(E2), and many gene–diet links are weakly established (E4).
This means personalized nutrition based on DNA is still developing, not definitive science.
Personalization sounds precise, but evidence shows a more uncertain picture.

Clarity comes from understanding both potential and limits.

If you’re considering using genetic-based nutrition advice, it may help to treat it as one piece of information — not a complete answer — and to focus first on well-established nutrition habits that apply broadly.

💭REFLECTION PROMPT

Something to reflect on…
When something feels highly personalized and scientific, what makes it feel trustworthy to you?

📬OUTRO & CTA

If you found this useful, follow Beyond the Buzz and share it with a friend who likes a little science with their scroll.
You can also explore the full transcript, the clarity poll, and evidence in The Evidence Edit.

Until next time, stay curious — and stay kind to your mind.

This is Beyond the Buzz — cutting through the hype, because evidence is empowering.

Next week: How Much Does Money Really Affect Happiness?

📊 POLL

📚REFERENCES — What’s the Hype (H1–H#) / What’s the Evidence (E1–E#)

🔓 Open Access |🔒Paywalled

H1
ISOGG Wiki. (n.d.). Autosomal DNA testing comparison chart (compiled by Tim Janzen). ISOGG. Metric value at reporting (observed March 20, 2026), from • Number of people in the database (as of 16 Mar 2026): https://isogg.org/wiki/Autosomal_DNA_testing_comparison_chart (Value at reporting: 56,592,196) Note: This value is a constructed summary derived from individual company database counts listed on the source page. Note: Platform engagement metrics are dynamic, real-time cumulative values and change over time.

H2
Fortune Business Insights. (2025). Personalized Nutrition Market Size, Share, Growth Report, 2034. Fortune Business Insights. https://www.fortunebusinessinsights.com/personalized-nutrition-market-106054 🔒

E1
King, A., Graham, C. A.-M., Glaister, M., Da Silva Anastacio, V., Pilic, L., & Mavrommatis, Y. (2023). The efficacy of genotype-based dietary or physical activity advice in changing behavior to reduce the risk of cardiovascular disease, type II diabetes mellitus or obesity: a systematic review and meta-analysis. Nutrition Reviews, 81(10), 1235-1253. https://doi.org/10.1093/nutrit/nuad001 🔒

E2
Jinnette, R., Narita, A., Manning, B., McNaughton, S. A., Mathers, J. C., & Livingstone, K. M. (2021). Does Personalized Nutrition Advice Improve Dietary Intake in Healthy Adults? A Systematic Review of Randomized Controlled Trials. Advances in Nutrition, 12(3), 657-669. https://doi.org/10.1093/advances/nmaa144 🔓

E3
Stewart, K. F. J., Wesselius, A., Schreurs, M. A. C., Schols, A. M. W. J., & Zeegers, M. P. (2018). Behavioural changes, sharing behaviour and psychological responses after receiving direct-to-consumer genetic test results: a systematic review and meta-analysis. Journal of Community Genetics, 9(1), 1-18. https://doi.org/10.1007/s12687-017-0310-z 🔓

E4
Keathley, J., Garneau, V., Zavala-Mora, D., Heister, R. R., Gauthier, E., Morin-Bernier, J., Green, R., & Vohl, M.-C. (2021). A Systematic Review and Recommendations Around Frameworks for Evaluating Scientific Validity in Nutritional Genomics. Frontiers in Nutrition, 8, 789215. https://doi.org/10.3389/fnut.2021.789215 🔓

E5
Braakhuis, A., Monnard, C. R., Ellis, A., & Rozga, M. (2021). Consensus Report of the Academy of Nutrition and Dietetics: Incorporating Genetic Testing into Nutrition Care. Journal of the Academy of Nutrition and Dietetics, 121(3), 545-552. https://doi.org/10.1016/j.jand.2020.04.002 🔒

🎧 Prefer to listen?
Listen to Can DNA Tests Personalize Your Diet? Evidence on Genetic Nutrition Advice on the Beyond the Buzz website — or follow Beyond the Buzz in your favourite podcast app.

Educational content only. This publication does not provide individualized medical, psychological, or professional advice.
Full disclaimer: beyondthebuzzmedia.com/disclaimer

This post includes the full transcript of this week’s Beyond the Buzz episode, followed by the clarity poll and full evidence.

🎧INTRO

Welcome to Beyond the Buzz — where curiosity meets clarity.
I’m Dr. Tara Moroz, scientist and communicator with decades of experience translating complex human research into clear, evidence-informed insight.

Today we’re looking at detox cleanses versus how your body actually detoxifies itself.
Many people are looking for ways to feel better, lose weight, or “reset” after periods of stress or overindulgence.
But mixed messaging about detox can lead people to spend time, money, and mental energy chasing benefits that aren’t always clear.
It sounds simple, but the science behind detox is often misunderstood.

Let’s take a closer look together — starting with what’s driving the buzz.

📊THE BUZZ

This trend is widely visible right now.

On TikTok, the hashtag #detox has been used in over 3 million posts overall (H1).

And beyond social media, there’s a massive industry behind it.
The global detox products market was valued at over 71 billion US dollars in 2025 (H2).

That includes juices, teas, supplements, and programs that promise to “cleanse” your body, remove toxins, and improve health.

The messaging is often framed simply: that the body builds up toxins and needs help to clear them out.

🧾RECEIPT CHECK

Let’s check the evidence — our kind of receipt check.

This is the moment to pause and ask the questions that matter — what’s the evidence, what’s the source, and how do we know?

🔬WHAT THE EVIDENCE SHOWS

Here’s what the evidence shows.

First, detox diets — meaning short-term programs that claim to remove toxins — have been studied in scientific reviews.
A review is a study that looks at all available research on a topic.

One critical review found there is very limited evidence that detox diets remove toxins or lead to sustained weight loss (E1).

Another review of alternative detox approaches also concluded that claims about toxin removal are not supported by strong scientific evidence (E2).

So what about the idea of “toxins” building up in the body?

In everyday language, “toxins” can refer to many different substances, but the body is constantly processing and eliminating these through normal physiology.

Your body already has systems designed to handle this.
The liver processes substances so they can be removed.
The kidneys filter waste from the blood.
The gut helps eliminate waste through digestion.

This is physiological detoxification — your body’s natural process of breaking down and removing potentially harmful substances.

The core biology of how the body processes and eliminates substances is well understood based on established scientific knowledge (E3)(E4).
What’s notable is not that the evidence is old — it’s that overall, the evidence remains limited and does not strongly support detox cleanses providing benefit beyond these established systems (E1)(E2).

There is evidence that certain foods can influence these processes by supporting the body’s own detox pathways — the chemical systems used to process substances (E3).
For example, dietary fiber — found in foods like fruits, vegetables, and whole grains — helps support the gut, liver, and kidneys in managing waste and maintaining normal function (E4).

But this is not the same as a short-term “cleanse.”
These effects come from consistent dietary patterns, not quick fixes.

Some people may feel short-term changes during a cleanse, but evidence does not support lasting detox benefits.

Overall, the evidence suggests that while the body has effective detox systems, there is limited evidence that commercial detox programs provide benefits beyond these established systems (E1)(E2)(E3)(E4).

🧠WHY THIS TREND RESONATES

So why does this trend resonate?

It likely taps into something deeper.

The idea of a “reset” is very appealing.
It offers a clear action when people feel off, tired, or out of balance.

Detox messaging also simplifies complex biology into a single story — toxins in, toxins out.

And in a busy world, a short program can feel more manageable than long-term habits.

🧭THE TAKEAWAY

So what’s the takeaway?

The body already has built-in systems to process and remove substances.
Evidence does not strongly support detox cleanses as effective for toxin removal or providing lasting health benefits.
Some foods can support normal metabolic processes, but this happens over time, not through short-term programs.

It’s easy to feel like you need a reset to feel better.

Your Evidence Edit moment:
Detox is often sold as a reset, but evidence for cleanses is limited.
The strongest evidence supports the body’s own detox systems, with limited evidence that commercial cleanse products add benefit beyond those systems (E1)(E2)(E3)(E4).
Detox is a process, not a product.

Before trying a detox product, it can be helpful to consider whether there’s evidence of benefit beyond what your body already does.

💭REFLECTION PROMPT

Something to reflect on…
When you hear the word “detox,” what do you picture — and where did that idea come from?

📬OUTRO & CTA

If you found this useful, follow Beyond the Buzz and share it with a friend who likes a little science with their scroll.
You can also explore the full transcript, the clarity poll, and evidence in The Evidence Edit.

Until next time, stay curious — and stay kind to your mind.

This is Beyond the Buzz — cutting through the hype, because evidence is empowering.

Next week: Can DNA Tests Really Personalize Your Diet?

📊 POLL

📚REFERENCES — What’s the Hype (H1–H#) / What’s the Evidence (E1–E#)

🔓 Open Access |🔒Paywalled

H1
TikTok. (n.d.). Creative Center — Trend Hashtag (#detox). TikTok. Metric value at reporting (observed March 19, 2026), from • Hashtag: https://ads.tiktok.com/business/creativecenter/hashtag/detox/pc/en?countryCode=US&period=7 (Value at reporting: 3M Overall) Note: Platform engagement metrics are dynamic, real-time cumulative values and change over time.

H2
Fortune Business Insights. (2025). Detox Products Market Size, Share, Growth, Forecast, 2034. Fortune Business Insights. https://www.fortunebusinessinsights.com/detox-products-market-112557 🔒

E1
Klein, A. V., & Kiat, H. (2015). Detox diets for toxin elimination and weight management: a critical review of the evidence. Journal of Human Nutrition and Dietetics, 28(6), 675–686. https://doi.org/10.1111/jhn.12286 🔒

E2
Ernst, E. (2012). Alternative detox. British Medical Bulletin, 101, 33–38. https://doi.org/10.1093/bmb/lds002 🔒

E3
Hodges, R. E., & Minich, D. M. (2015). Modulation of Metabolic Detoxification Pathways Using Foods and Food-Derived Components: A Scientific Review with Clinical Application. Journal of Nutrition and Metabolism, 2015, 760689. https://doi.org/10.1155/2015/760689 🔓

E4
Kieffer, D. A., Martin, R. J., & Adams, S. H. (2016). Impact of Dietary Fibers on Nutrient Management and Detoxification Organs: Gut, Liver, and Kidneys. Advances in Nutrition, 7(6), 1111–1121. https://doi.org/10.3945/an.116.013219 🔓

🎧 Prefer to listen?
Listen to Do Detox Cleanses Work? Understanding Natural Detoxification vs Cleanses on the Beyond the Buzz website — or follow Beyond the Buzz in your favourite podcast app.

Educational content only. This publication does not provide individualized medical, psychological, or professional advice.
Full disclaimer: beyondthebuzzmedia.com/disclaimer

This post includes the full transcript of this week’s Beyond the Buzz episode, followed by the clarity poll and full evidence.

Thank you to this week’s guest, Wes Michael, Founder, Rare Patient Voice.

🎧INTRO

Welcome to Beyond the Buzz — where curiosity meets clarity.

I’m Dr. Tara Moroz, scientist and communicator with decades of experience translating complex human research into clear, evidence-informed insight.

Today we’re looking at how people decide whether to participate in clinical research — something more people are encountering than ever before — a decision that sits at the intersection of science, personal health, and the growing ways technology connects people to research opportunities.

Many people first encounter research participation through an invitation — from a clinic, a patient organization, a website, or sometimes even social media — or after a diagnosis, when they begin looking into treatment advances.

For some, that invitation sparks curiosity. For others, it raises questions about safety, time commitments, or whether participation is the right choice.

To explore how people think about these decisions, I spoke with Wes Michael, founder of Rare Patient Voice — an organization that connects patients and care partners with opportunities to participate in healthcare research.

Let’s take a closer look together — starting with what’s driving the buzz.

📊THE BUZZ

Clinical research depends on people choosing to participate, yet participation remains relatively uncommon.

One example comes from a large U.S. survey of cancer survivors, which found that many people know about clinical trials but far fewer ever join one. Nearly 78% said they had some knowledge of clinical trials, but only about 15% had discussed them with a doctor, and fewer than 8% had participated. (H1)

That gap between awareness and participation creates a practical challenge for researchers.

Clinical studies rely on volunteers, and many trials struggle to enroll enough participants to answer their research questions. (E2)

Because recruitment is so important, an entire industry has developed to help studies find participants. The global clinical trial patient recruitment services market was valued at almost 11 billion U.S. dollars in 2024 and is projected to reach almost 23 billion dollars by 2033. (H2)

As more systems connect patients with research opportunities, more people may encounter invitations to participate in studies.
But seeing an invitation is only the first step.

That raises an important question: when people encounter an invitation to participate in research, what influences their decision to take part — or not?

🧾RECEIPT CHECK

Let’s check the evidence — our kind of receipt check.

This is the moment to pause and ask the questions that matter — what’s the evidence, what’s the source, and how do we know?

🔬WHAT THE EVIDENCE SHOWS

Here’s what the evidence shows about how people make these decisions.

Researchers often study participation using systematic reviews — studies that summarize findings across many individual research papers. (E1)

Across these reviews, several factors consistently influence whether people consider participating in research. (E1)(E4)

Trust plays an important role. People are more likely to consider research when they trust the researchers, healthcare providers, or institutions involved. (E1)

Clear information also matters. Potential participants want understandable explanations about what the study involves, including possible benefits, risks, and time commitments. (E2)

Practical considerations can also influence decisions. Travel requirements, time demands, or complex procedures may make participation difficult for some volunteers. (E2)

Personal motivations also shape decisions. Some participants hope for access to new treatments, while others want to contribute to science or help future patients with the same condition. (E3)

Concerns can influence decisions too. People sometimes worry about safety, side effects, or being assigned to a comparison group rather than receiving a new treatment. (E1)

Research also suggests that decision-support tools may help people evaluate these choices. Clear information guides or structured discussions with clinicians can support people in understanding their options. (E5)

Importantly, these tools are designed to support informed decisions — not to persuade people to participate. (E5)

🧠WHY THIS TREND RESONATES

So why does this trend resonate?

For many people, invitations to participate in research are unfamiliar experiences.

When those invitations appear, people often weigh several considerations at once: trust, safety, time, and whether participation aligns with their values.

At the same time, some people feel motivated by the opportunity to contribute to scientific progress or help others facing similar health challenges. (E3)

These mixed motivations help explain why participation decisions can feel personal and complex.

Research suggests people rarely base these decisions on a single factor.
So what does that look like in real life?

🧭THE TAKEAWAY and GUEST INSIGHTS

To explore that, I spoke with Wes Michael from Rare Patient Voice, who regularly hears from patients and care partners considering research participation.

Wes, when people first encounter an opportunity to participate in a research study, what questions or concerns do they most often raise?

[Wes: They certainly want to know if it applies to them or their loved one’s condition. But a key area that is often overlooked is, they want to know how they can fit the trial into their everyday life. In addition to being a patient or caregiver, they’re moms and dads, they have jobs and interests. They don’t want their lives turned upside down. They have to figure out how to make the trial a part of their life without giving up the rest of their life.]

Research also shows that motivations vary widely — from curiosity about new treatments to a desire to contribute to science. (E3)

From your conversations with patients and care partners, what do people often say they gain — or hope to gain — from sharing their experiences in research?

[Wes: They want those developing and marketing treatments to understand what they want and need. Sure, they want a cure, or an effective treatment, but they also want to enjoy some quality of life. Many have had very difficult experiences, getting misdiagnosed or being ignored, and they want their story to be heard by those who are making the decisions.]

And for someone who encounters a study invitation but isn’t sure what to do next, what advice would you offer when deciding whether participation feels right for them?

[Wes: They need to feel free to ask any questions they have and not leave until they are satisfied with answers that they can understand. They should trust their gut – are they getting the right vibes that this feels right for them? Also, they should talk with others they may know in the same disease community about the research. Compare their thoughts with others as they make a decision.]

Thanks Wes!

So what’s the takeaway?

Decisions about research participation are really decisions about health and how people engage with science — shaped by factors like trust, clear information, practical feasibility, and personal motivations. (E1)(E2)(E4)

If you’re curious about research opportunities, a few starting points can help.
Public registries list clinical studies searchable by condition, location, or treatment type. One example is ClinicalTrials.gov, a publicly accessible database where studies are registered and described — although these platforms are often designed with researchers in mind and can be difficult to navigate. In many cases, a healthcare provider can help identify studies that may be relevant.

Rare Patient Voice — the organization Wes founded — is one example of a community that connects patients and care partners with research opportunities.

When evaluating a study invitation, look for clear explanations of the study’s purpose, what participation involves, possible risks and benefits, and how your data will be used — and take time to ask questions or go back over anything that isn’t clear.

Your Evidence Edit Moment:

Most people think deciding whether to participate in research is mainly about the science.

But strong evidence from multiple systematic reviews shows that people weigh several factors together — including trust, clear information, practical barriers, and personal motivations. (E1)(E4)

In reality, participation decisions are rarely about science alone.
They’re also shaped by everyday realities like time, logistics, safety concerns, and personal values. (E2)(E3)

Learning more can help you decide whether participation feels right for you.

💭REFLECTION PROMPT

Something to reflect on…
If you were invited to participate in a clinical study, what information would help you feel comfortable making that decision?

📬OUTRO & CTA

If you found this useful, follow Beyond the Buzz and share it with a friend who likes a little science with their scroll.

You can explore the transcript, evidence, and this week’s clarity poll in The Evidence Edit.

Until next time, stay curious — and stay kind to your mind.

This is Beyond the Buzz — cutting through the hype, because evidence is empowering.

Next week: Do Detox Cleanses Actually Help Your Body?

📊 POLL

📚REFERENCES — What’s the Hype (H1–H#) / What’s the Evidence (E1–E#)

🔓 Open Access |🔒Paywalled

H1
HINTS. (2021). HINTS Brief 57 — Clinical Trial Knowledge, Discussion, and Participation Among Cancer Survivors. HINTS. https://hints.cancer.gov/docs/Briefs/HINTS_Brief_57.pdf 🔓

H2
Grand View Research. (2024). Clinical Trial Patient Recruitment Services Market Report. Grand View Research. https://www.grandviewresearch.com/industry-analysis/clinical-trial-patient-recruitment-services-market-report 🔓

E1
Rodríguez-Torres, E., González-Pérez, M. M., & Díaz-Pérez, C. (2021). Barriers and facilitators to the participation of subjects in clinical trials: An overview of reviews. Contemporary Clinical Trials Communications, 23, 100829. https://doi.org/10.1016/j.conctc.2021.100829 🔓

E2
Houghton, C., Dowling, M., Meskell, P., Hunter, A., Gardner, H., Conway, A., Treweek, S., Sutcliffe, K., Noyes, J., Devane, D., Nicholas, J. R., & Biesty, L. M. (2020). Factors that impact on recruitment to randomised trials in health care: a qualitative evidence synthesis. Cochrane Database of Systematic Reviews, 2020(10), MR000045. https://doi.org/10.1002/14651858.MR000045.pub2 🔓

E3
Dobra, R., Wilson, G., Matthews, J., Boeri, M., Elborn, S., Kee, F., Davies, J. C., & Madge, S. (2023). A systematic review to identify and collate factors influencing patient journeys through clinical trials. JRSM Open, 14(6), 20542704231166621. https://doi.org/10.1177/20542704231166621 🔓

E4
Knapp, P., Bower, P., Lidster, A., O’Hare, H., Ferreira Sol, L., Golder, S., Keyworth, C., Parker, A., & Sheridan, R. (2025). Why do patients take part in research? An updated overview of systematic reviews of psychosocial barriers and facilitators. Trials, 26(1), 174. https://doi.org/10.1186/s13063-025-08850-6 🔓

E5
Hersch, J., O’Hara, L., Juraskova, I., Laidsaar-Powell, R., Bartley, N., Gillies, K., Ballinger, M., Wang, W., & Butow, P. (2025). Interventions to support patient decision making about taking part in health research: A systematic review. Patient Education and Counseling, 141, 109339. https://doi.org/10.1016/j.pec.2025.109339 🔓

🎧 Prefer to listen?
Listen to How People Decide to Join Clinical Trials and Research Studies on the Beyond the Buzz website — or follow Beyond the Buzz in your favourite podcast app.

Educational content only. This publication does not provide individualized medical, psychological, or professional advice.
Full disclaimer: beyondthebuzzmedia.com/disclaimer

This post includes the full transcript of this week’s Beyond the Buzz episode, followed by the clarity poll and full evidence.

🎧INTRO

Welcome to Beyond the Buzz — where curiosity meets clarity.
I’m Dr. Tara Moroz, scientist and communicator with decades of experience translating complex human research into clear, evidence-informed insight.

Today we’re talking about influencer-driven health advice and the idea of authenticity online.

You might see creators sharing health tips, routines, or personal experiences across social media.
When confident advice appears everywhere, sorting signal from noise can quietly drain your time and attention.

Authenticity can feel trustworthy — but what does trust actually mean online?

Let’s take a closer look together — starting with what’s driving the buzz.

📊THE BUZZ

Across social media, health advice has become a major category of content.

On TikTok alone, more than 300,000 posts use the hashtag #healthtok (H1). That scale shows just how large the health conversation online has become.

At the same time, the influencer economy itself is rapidly expanding. One market report estimates the global influencer marketing platform market was valued at over 25 billion dollars in 2024 and could reach almost 98 billion dollars by 2030 (H2).

That growth helps explain why health advice, lifestyle routines, and personal wellness stories are everywhere in the scroll, and why influencers are increasingly promoting health-related content.

Influencers often present information through personal stories, daily habits, or product recommendations. Many emphasize authenticity — meaning they appear relatable, honest, and open about their lives.

And online, “influencer” can mean almost anyone — from lifestyle creators to licensed professionals — but credentials alone don’t guarantee that the advice shared reflects the full scientific evidence.

For viewers, that authenticity can feel more trustworthy than traditional health messaging.

And that raises a question many people are now asking: can you trust health advice from influencers?

Popularity and authenticity are not the same as accuracy and credibility.

🧾RECEIPT CHECK

Let’s check the evidence — our kind of receipt check.

This is the moment to pause and ask the questions that matter — what’s the evidence, what’s the source, and how do we know?

🔬WHAT THE EVIDENCE SHOWS

Here’s what the evidence shows.

Researchers have studied how social media health content — including influencer content — affects people’s understanding and health behavior.

A systematic review — a study that reviews all available research on a topic — found that health influencers can shape attitudes and behaviors, sometimes positively and sometimes negatively (E1). Their reach and personal storytelling can influence how audiences perceive health information.

Research suggests that storytelling, relatability, and frequent exposure can shape how people think about health decisions (E1).

At the same time, research consistently finds that health misinformation is common on social media platforms (E2). A systematic review examining multiple platforms found that the share of inaccurate or misleading health information in social media studies ranged from less than 1 percent to nearly 30 percent depending on the topic and platform (E2).

Another systematic review describes this broader environment as an “infodemic.” That term refers to the rapid spread of both accurate and inaccurate health information during major public conversations about health (E3).

Studies specifically examining TikTok health content show similar patterns. Reviews of youth mental health content on the platform found that videos often mix helpful information with incomplete explanations or unsupported claims (E4). In other words, some influencer health content can be useful, but accuracy varies widely across posts (E2)(E4).

And when people judge whether health content is trustworthy online, credibility often depends on perceived authenticity — meaning how relatable or genuine the creator appears (E5).

In other words, people often evaluate the messenger as much as the message. And that messenger might be anyone — from a lifestyle creator to a licensed professional — but the accuracy of the information still depends on the evidence behind it.

🧠WHY THIS TREND RESONATES

So why does this trend resonate?

Part of the answer is human psychology.

People tend to trust information that comes through stories and personal experience, because stories feel easier to understand and remember than technical explanations. That can make influencer advice feel more trustworthy than traditional expert communication.

Influencers also reduce the distance between expert and audience. Instead of formal lectures or journal articles, viewers see someone in their kitchen, gym, or living room.

That setting can make information feel more relatable and accessible.

Authenticity also matters in digital culture. When creators share personal struggles, daily routines, or vulnerable moments, audiences may feel a stronger emotional connection.

Research on health communication shows that perceived authenticity can shape how credible content feels to audiences, even when the scientific evidence behind the claims is unclear (E5).

So the appeal is understandable.

But relatability is not the same as reliability.

And popularity is not a measure of evidence quality.

🧭THE TAKEAWAY

So what’s the takeaway?

Research shows that health influencers can strongly shape public understanding of health topics, largely because of their reach and personal storytelling (E1). But the same research environment also shows widespread misinformation and mixed quality of health content across social media platforms (E2)(E3)(E4).

That can leave many people unsure whether health advice they see online is actually reliable.

Your Evidence Edit moment:
Mixed evidence shows that social media influencers can shape health beliefs and behaviors, but the information shared online often varies widely in accuracy and completeness (E1)(E2)(E3)(E4). Perceived authenticity — how genuine or relatable a creator seems — can strongly influence credibility, even when the scientific evidence is uncertain or incomplete (E5).
Authenticity builds attention; evidence determines what truly holds up.
Research suggests that pausing to reflect on accuracy can help people better evaluate information they encounter online (E6).

When you see health advice online, it can help to ask a few simple questions:

• Is the claim based mainly on someone’s personal experience — or does it explain what evidence supports it?

• Does the message sound balanced, or unusually confident and dramatic?

• And does the advice broadly reflect what larger scientific studies and health experts say — or mainly one person’s view?

Asking those questions can make it easier to recognize when health advice is grounded in evidence — and when it’s mainly a personal story.

💭REFLECTION PROMPT

Something to reflect on…
When a creator feels authentic and relatable, what signals help you decide whether their health advice is trustworthy?

📬OUTRO & CTA

If you found this useful, follow Beyond the Buzz and share it with a friend who likes a little science with their scroll.

You can also explore the full transcript, the clarity poll, and evidence in The Evidence Edit.

Until next time, stay curious — and stay kind to your mind.

This is Beyond the Buzz — cutting through the hype, because evidence is empowering.

Next week: How People Decide on Clinical Research Participation

📊 POLL

📚REFERENCES — What’s the Hype (H1–H#) / What’s the Evidence (E1–E#)

🔓 Open Access |🔒Paywalled

H1

TikTok. (n.d.). Creative Center — Trend Hashtag (#healthtok). TikTok.
Metric value at reporting (observed March 5, 2026), from
• Hashtag: https://ads.tiktok.com/business/creativecenter/hashtag/healthtok/pc/en?countryCode=US&period=30 (Value at reporting: 314K posts)

Note: Platform engagement metrics are dynamic, real-time cumulative values and change over time.

H2

Grand View Research. (n.d.). Influencer marketing platform market size report, 2030. Grand View Research. https://www.grandviewresearch.com/industry-analysis/influencer-marketing-platform-market

E1

Powell, J., & Pring, T. (2024). The impact of social media influencers on health outcomes: Systematic review. Soc Sci Med, 340, 116472. https://doi.org/10.1016/j.socscimed.2023.116472 🔓

E2

Suarez-Lledo, V., & Alvarez-Galvez, J. (2021). Prevalence of Health Misinformation on Social Media: Systematic Review. J Med Internet Res, 23(1), e17187. https://doi.org/10.2196/17187 🔓

E3

Borges do Nascimento, I. J., Pizarro, A. B., Almeida, J. M., Azzopardi-Muscat, N., Gonçalves, M. A., Björklund, M., & Novillo-Ortiz, D. (2022). Infodemics and health misinformation: a systematic review of reviews. Bull World Health Organ, 100(9), 544–561. https://doi.org/10.2471/BLT.21.287654 🔓

E4

McCashin, D., & Murphy, C. M. (2023). Using TikTok for public and youth mental health – A systematic review and content analysis. Clin Child Psychol Psychiatry, 28(1), 279–306. https://doi.org/10.1177/13591045221106608 🔓

E5

Jenkins, E. L., Ilicic, J., Barklamb, A. M., & McCaffrey, T. A. (2020). Assessing the Credibility and Authenticity of Social Media Content for Applications in Health Communication: Scoping Review. J Med Internet Res, 22(7), e17296. https://doi.org/10.2196/17296 🔓

E6

Pennycook, G., McPhetres, J., Zhang, Y., Lu, J. G., & Rand, D. G. (2021). Shifting attention to accuracy can reduce misinformation online. Nature, 592, 590–595. https://doi.org/10.1038/s41586-021-03344-2 🔒

🎧 Prefer to listen?
Listen to Influencer Health Advice: Authenticity vs Evidence on the Beyond the Buzz website — or follow Beyond the Buzz in your favourite podcast app.

Educational content only. This publication does not provide individualized medical, psychological, or professional advice.
Full disclaimer: beyondthebuzzmedia.com/disclaimer

This post includes the full transcript of this week’s Beyond the Buzz episode, followed by the clarity poll and full evidence.

🎧INTRO

Welcome to Beyond the Buzz — where curiosity meets clarity.
I’m Dr. Tara Moroz, scientist and communicator with decades of experience translating complex human research into clear, evidence-informed insight.

Today, we’re talking about cortisol, stress hormones, and weight gain claims. Cortisol is a hormone — a chemical messenger in the body — that helps regulate stress and energy.

You might be seeing videos that say stress is the hidden reason your weight won’t budge. Sorting through confident claims can quietly drain your time and focus.

The story sounds simple — but biology rarely is.

Let’s take a closer look together — starting with what’s driving the buzz.

📊THE BUZZ

Scroll for a few minutes and you’ll likely see it.

On TikTok alone, more than 600,000 posts use the hashtag #cortisol (H1).

Alongside that visibility is a growing product market. One report estimates that the global cortisol support supplement market reached over 1.5 billion U.S. dollars in 2024 (H2).

The message is often presented as clear and compelling. Stress raises cortisol. Cortisol causes weight gain. Lower cortisol and the weight will drop.

It’s a tidy explanation. And tidy explanations travel well.

🧾RECEIPT CHECK

Let’s check the evidence — our kind of receipt check.

This is the moment to pause and ask the questions that matter — what’s the evidence, what’s the source, and how do we know?

🔬WHAT THE EVIDENCE SHOWS

Here’s what the evidence shows.

A 2011 meta-analysis — a study that combines results from many studies — looked at long-term research on stress and body fat (E1). It found that higher stress was associated with higher body fat (E1). The effects were modest (E1).
That matters — it suggests stress is one factor among many, not a single dominant cause.

A 2015 systematic review — a study that reviews all available research on a topic — examined the body’s central stress response system and cortisol patterns in obesity (E2). It found altered cortisol patterns, but results were inconsistent and varied by how cortisol was measured (E2).

In other words, cortisol activity in obesity is complex. It does not follow one simple pattern (E2).

A 2022 systematic review and meta-analysis looked at stress and eating behaviours in healthy adults (E3). It found that stress was linked to changes in eating, including increased intake for some people (E3). But responses differed. Some people ate more under stress. Others ate less (E3).

That variability is important.

Another 2022 meta-analysis measured long-term cortisol levels using hair samples (E4). Hair cortisol reflects longer-term exposure rather than moment-to-moment changes. This review found cross-sectional associations — meaning measured at one point in time — between higher hair cortisol and higher body measurements (E4). Cross-sectional studies cannot show cause and effect (E4).

Finally, clinical practice guidelines from the Endocrine Society on Cushing’s syndrome — a condition of chronically high cortisol — state that sustained, medically significant cortisol excess is associated with weight gain and metabolic complications (E5). Cushing’s syndrome is rare and distinct from everyday stress (E5).

So severe, sustained cortisol excess in Cushing’s syndrome is associated with significant weight and metabolic changes (E5). But everyday stress-related cortisol patterns reflect normal stress responses — not the sustained, medically abnormal cortisol excess seen in Cushing’s syndrome (E2)(E5).

🧠WHY THIS TREND RESONATES

So why does this trend resonate?

Stress feels real. Weight changes are real. Linking the two creates a clear story.

It also shifts the focus from personal discipline to biology. That can feel validating.

And when social media offers a simple lever — “lower cortisol” — it creates a sense of control. In a complex world, control is comforting.

But comfort and causation are not the same thing.

🧭THE TAKEAWAY

So what’s the takeaway?

Across systematic reviews and meta-analyses, stress shows modest associations with body fat and eating behaviours, with wide individual variation (E1)(E3)(E4). Altered cortisol patterns are observed in obesity, but findings are mixed and measurement-dependent (E2). Clear, strong weight effects are seen in rare medical conditions with sustained high cortisol, not typical daily stress (E5).

You might be wondering:

Does cortisol cause weight gain?
In rare medical conditions with chronically high cortisol, weight gain is well documented (E5). In everyday stress, associations with body fat are modest and variable (E1)(E4).

Can lowering cortisol help you lose weight?
Studies summarized here show modest and inconsistent links between cortisol and body weight (E1–E4). They do not directly evaluate whether lowering typical stress-related cortisol changes leads to predictable weight loss. Weight regulation involves many biological and behavioural factors beyond a single hormone.

Do cortisol supplements have strong evidence for weight loss?
The research summarized here does not demonstrate that everyday cortisol variation is a dominant driver of weight gain (E1–E4). Strong metabolic effects are seen in rare endocrine disorders, not typical stress exposure (E5).

If you’re considering a product that claims to “lower cortisol for weight loss,” pause and ask whether the evidence reflects rare medical conditions or typical daily stress.

It’s understandable to want one clear explanation.

Your Evidence Edit moment:

Mixed evidence suggests stress and cortisol are associated with body weight, but the effects are modest, variable, and not a single direct cause (E1)(E2)(E3)(E4). Strong effects on weight are documented in medical conditions with chronically high cortisol, not typical day-to-day stress (E5). Stress matters, but it operates within a broader web of biology and behaviour (E1)(E3). Hormones influence weight, but they rarely act alone.

Understanding complexity is a form of empowerment.

💭REFLECTION PROMPT

Something to reflect on…
When you hear a simple hormone explanation for weight change, what questions could you ask about the size of the effect, the type of evidence, and whether it reflects everyday life or a medical condition?

📬OUTRO & CTA

If you found this useful, follow Beyond the Buzz and share it with a friend who likes a little science with their scroll.

You can also explore the full transcript, the clarity poll, and evidence in The Evidence Edit.

Until next time, stay curious — and stay kind to your mind.

This is Beyond the Buzz — cutting through the hype, because evidence is empowering.

Next week: Influencer Health Advice and the Meaning of Authenticity

📊 POLL

📚REFERENCES — What’s the Hype (H1–H#) / What’s the Evidence (E1–E#)

🔓 Open Access |🔒Paywalled

H1

TikTok. (n.d.). Creative Center — Trend Hashtag (#cortisol). TikTok.
Metric value at reporting (observed March 5, 2026), from
• Hashtag: https://ads.tiktok.com/business/creativecenter/hashtag/cortisol/pad/en?countryCode=US&period=30 (Value at reporting: 663K posts)

Note: Platform engagement metrics are dynamic, real-time cumulative values and change over time.

H2

DataIntelo. (2025). Cortisol support supplement market — global industry analysis, growth, share, size, trends, and forecast 2025-2033. DataIntelo. https://dataintelo.com/report/cortisol-support-supplement-market

E1

Wardle, J., Chida, Y., Gibson, E. L., Whitaker, K. L., & Steptoe, A. (2011). Stress and adiposity: a meta-analysis of longitudinal studies. Obesity (Silver Spring), 19(4), 771-8. https://doi.org/10.1038/oby.2010.241 🔓

E2

Incollingo Rodriguez, A. C., Epel, E. S., White, M. L., Standen, E. C., Seckl, J. R., & Tomiyama, A. J. (2015). Hypothalamic-pituitary-adrenal axis dysregulation and cortisol activity in obesity: A systematic review. Psychoneuroendocrinology, 62, 301-18. https://doi.org/10.1016/j.psyneuen.2015.08.014 🔓

E3

Hill, D., Conner, M., Clancy, F., Moss, R., Wilding, S., Bristow, M., & O’Connor, D. B. (2022). Stress and eating behaviours in healthy adults: a systematic review and meta-analysis. Health Psychol Rev, 16(2), 280-304. https://doi.org/10.1080/17437199.2021.1923406 🔓

E4

van der Valk, E., Abawi, O., Mohseni, M., Abdelmoumen, A., Wester, V., van der Voorn, B., Iyer, A., van den Akker, E., Hoeks, S., van den Berg, S., de Rijke, Y., Stalder, T., & van Rossum, E. (2022). Cross-sectional relation of long-term glucocorticoids in hair with anthropometric measurements and their possible determinants: A systematic review and meta-analysis. Obes Rev, 23(3), e13376. https://doi.org/10.1111/obr.13376 🔓

E5

Nieman, L. K., Biller, B. M. K., Findling, J. W., Murad, M. H., Newell-Price, J., Savage, M. O., Tabarin, A., & Endocrine Society. (2015). Treatment of Cushing’s Syndrome: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab, 100(8), 2807-31. https://doi.org/10.1210/jc.2015-1818 🔓

🎧 Prefer to listen?
Listen to Cortisol and Weight Gain: What the Evidence Shows About Stress and Hormones on the Beyond the Buzz website — or follow Beyond the Buzz in your favourite podcast app.

Educational content only. This publication does not provide individualized medical, psychological, or professional advice.
Full disclaimer: beyondthebuzzmedia.com/disclaimer

This post includes the full transcript of this week’s Beyond the Buzz episode, followed by the clarity poll and full evidence.

🎧INTRO

Welcome to Beyond the Buzz — where curiosity meets clarity.

I’m Dr. Tara Moroz, scientist and communicator with decades of experience translating complex human research into clear, evidence-informed insight.

Today, we’re talking about placebo effects in wellness practices — the real, measurable effects that can happen when people expect a treatment to help.

A placebo is a treatment that doesn’t have a specific active effect on the condition being treated, yet the experience of receiving it — and expecting it to help — can still influence symptoms.

You might be trying meditation, supplements, acupuncture, energy healing, crystals, bodywork, or other wellness services — and wondering what is actually doing the work.

When the messaging is confident but the evidence is complex, it can quietly drain your time and money.

If it feels powerful, does that make it powerful?

Let’s take a closer look together — starting with what’s driving the buzz.

📊THE BUZZ

This conversation sits inside a much bigger wellness landscape.

In 2022, meditation was the most commonly used complementary health approach in the United States, used by over 17% of adults — nearly one in six (H1).

And the economics are just as striking.

The global wellness economy grew by almost 8% from 2023 to 2024 and reached almost 7 trillion U.S. dollars in 2024 (H2).

That scale shapes expectations around wellness practices (H2).

When an industry is that large, and participation is that common, stories about transformation travel fast (H1)(H2).

🧾RECEIPT CHECK

Let’s check the evidence — our kind of receipt check.

This is the moment to pause and ask the questions that matter — what’s the evidence, what’s the source, and how do we know?

🔬WHAT THE EVIDENCE SHOWS

Here’s what the evidence shows.

A Cochrane systematic review — a study that reviews all available research on a topic — examined placebo interventions across many clinical conditions (E1).

It found that placebos generally had little or no important effect on objective outcomes, such as blood pressure or measurable disease markers (E1).

However, the same review found that placebos could have small effects on subjective outcomes — like pain or how someone reports feeling (E1).

Subjective outcomes are experiences reported by the person, not directly measured by a device.

More recently, researchers have studied “open-label placebos” — placebos given honestly, where people are told they are receiving a placebo with no active ingredient (E2).

A systematic review and meta-analysis found that open-label placebos were associated with small to moderate improvements in some conditions compared to no treatment (E2).

That suggests expectations and context can influence outcomes, even without deception (E2).

Context appears especially relevant in pain care.

A 2024 systematic review in musculoskeletal pain found that contextual factors — such as clinician communication and the treatment setting — meaningfully contributed to outcomes in exercise-based or non-surgical treatments (E3).

In other words, part of the effect was linked to the surrounding experience, not only the specific technique (E3).

That distinction matters in many wellness settings — whether it is acupuncture, reiki, hands-on bodywork, or supplement protocols — where ritual, interaction with the practitioner, and expectation are built into the experience.

In weight loss research, a 2024 systematic review examined placebo and nocebo effects — nocebo meaning negative expectations that can worsen symptoms — in adults (E4).

The authors found evidence that expectations can influence weight-related outcomes, but effects varied and were generally modest (E4).

The findings highlighted that mindset can play a role, but it does not override biological processes or health behaviors. (E4).

And across healthcare more broadly, a systematic review found that the quality of the patient–clinician relationship was associated with better health outcomes (E5).

Empathy, listening, and trust were linked with measurable differences across conditions (E5).

Relationship is part of the treatment context (E5).

Taken together, the evidence suggests placebo and context effects are real, but typically modest and more consistent for subjective experiences than for objective biological measures (E1)(E2)(E3)(E4)(E5).

🧠WHY THIS TREND RESONATES

So why does this trend resonate?

Wellness practices often create strong rituals and meaning.

Rituals can shape expectations, and expectations can shape perception (E2)(E3).

Many of the elements that can drive improvement across very different interventions are surprisingly similar: time spent listening, validation, ritual, touch, empathy, and feeling seen.

Those elements can influence stress responses, attention to symptoms, and how the brain processes pain and discomfort (E2)(E5).

They are part of context.

Many wellness encounters involve time, attention, and feeling heard.

Evidence shows the patient–clinician relationship can influence outcomes (E5).

That kind of relational care can feel powerful.

And when nearly one in six adults uses a complementary approach like meditation (H1), shared experiences amplify belief and social proof (H1).

In a multi-trillion dollar global industry, compelling stories are part of the ecosystem (H2).

None of that means benefits are imagined.

It means human biology and psychology respond to context, expectation, and relationship (E1)(E2)(E5).

🧭THE TAKEAWAY

So what’s the takeaway?

Across many conditions, placebo and context effects are real but usually modest.

They appear strongest for how people feel — like pain or symptom reports — and less consistent for objective biological measures (E1)(E2)(E3)(E4).

The therapeutic relationship itself can meaningfully shape outcomes (E5).

It can be hard to untangle what comes from the specific technique — and what comes from expectation, context, and relationship.

Your Evidence Edit moment:

There is mixed evidence that placebo and context effects meaningfully influence subjective experiences like pain, but these effects are generally small and less reliable for objective disease outcomes (E1)(E2)(E3)(E4).

Strong therapeutic relationships are associated with better outcomes, suggesting context matters alongside any specific technique (E5).

Expectation shapes experience.

Context shapes outcomes.

But neither automatically proves that a specific mechanism — energy flow, detox pathways, crystal frequencies, or supplement blends — is responsible for the change.

Clarity comes from understanding both biology and belief.

💭REFLECTION PROMPT

Something to reflect on…
When you think about a wellness practice that felt helpful, what parts were the technique itself — and what parts were the time, attention, expectation, and relationship surrounding it? (E3)(E5)

📬OUTRO & CTA

If you found this useful, follow Beyond the Buzz and share it with a friend who likes a little science with their scroll.

You can also explore the full transcript, the clarity poll, and evidence in The Evidence Edit.

Until next time, stay curious — and stay kind to your mind.

This is Beyond the Buzz — cutting through the hype, because evidence is empowering.

Next week: Cortisol, Stress, and Weight Gain Claims

📊 POLL

📚REFERENCES — What’s the Hype (H1–H#) / What’s the Evidence (E1–E#)

🔓 Open Access |🔒Paywalled

REFERENCES

H1

Nahin, R. L., Rhee, A., & Stussman, B. (2024). Use of Complementary Health Approaches Overall and for Pain Management by US Adults. JAMA, 331(7), 613–615. https://doi.org/10.1001/jama.2023.26775 🔒

H2

Global Wellness Institute. (2024). 2024 global wellness economy monitor. Global Wellness Institute. https://globalwellnessinstitute.org/industry-research/2024-global-wellness-economy-monitor/ 🔓

E1

Hróbjartsson, A., & Gøtzsche, P. C. (2010). Placebo interventions for all clinical conditions. Cochrane Database of Systematic Reviews, 2010(1), CD003974. https://doi.org/10.1002/14651858.CD003974.pub3 🔓

E2

von Wernsdorff, M., Loef, M., Tuschen-Caffier, B., & Schmidt, S. (2021). Effects of open-label placebos in clinical trials: a systematic review and meta-analysis. Scientific Reports, 11(1), 3855. https://doi.org/10.1038/s41598-021-83148-6 🔓

E3

Saueressig, T., Owen, P. J., Pedder, H., Tagliaferri, S., Kaczorowski, S., Altrichter, A., Richard, A., Miller, C. T., Donath, L., & Belavy, D. L. (2024). The importance of context (placebo effects) in conservative interventions for musculoskeletal pain: A systematic review and meta-analysis of randomized controlled trials. European Journal of Pain, 28(5), 675–704. https://doi.org/10.1002/ejp.2222 🔒

E4

Żegleń, M., Kryst, Ł., & Bąbel, P. (2024). Diet, gym, supplements, or maybe it is all in your mind? A systematic review and meta-analysis of studies on placebo and nocebo effects in weight loss in adults. Obesity Reviews, 25(2), e13660. https://doi.org/10.1111/obr.13660 🔒

E5

Kelley, J. M., Kraft-Todd, G., Schapira, L., Kossowsky, J., & Riess, H. (2014). The influence of the patient-clinician relationship on healthcare outcomes: a systematic review and meta-analysis of randomized controlled trials. PLoS One, 9(4), e94207. https://doi.org/10.1371/journal.pone.0094207 🔓

🎧 Prefer to listen?
🎧 Prefer to listen?
Listen to Placebo Effects in Wellness: What the Evidence Shows on the Beyond the Buzz website — or follow Beyond the Buzz in your favourite podcast app.

Educational content only. This publication does not provide individualized medical, psychological, or professional advice.
Full disclaimer: beyondthebuzzmedia.com/disclaimer

This post includes the full transcript of this week’s Beyond the Buzz episode, followed by the clarity poll and full evidence.

🎧INTRO

Welcome to Beyond the Buzz — where curiosity meets clarity.

I’m Dr. Tara Moroz, scientist and communicator with decades of experience translating complex human research into clear, evidence-informed insight.

Today, we’re talking about GLP-1 medications and long-term weight regain after discontinuation — specifically semaglutide, sold under the brand names Ozempic and Wegovy, and tirzepatide, sold under the brand name Mounjaro.

These are prescription drugs that mimic a gut hormone to reduce appetite and support weight loss.

Many people are trying to decide whether starting — or stopping — these medications makes sense for them.

Mixed messages about what happens after stopping can create anxiety and second-guessing.

The promise sounds simple, but the long-term picture is more complex.

Let’s take a closer look together — starting with what’s driving the buzz.

📊THE BUZZ

It’s hard to miss how visible these medications have become.

About one in eight adults — 12% — say they are currently taking a GLP-1 drug such as Ozempic or Wegovy — brand names for the medication semaglutide — either to lose weight or to treat a chronic condition (H1).

The economic scale is also striking.

Novo Nordisk — the manufacturer of semaglutide — reported obesity care sales of roughly 12 billion U.S. dollars in 2025, a 31% increase compared to the previous year (H2).

Several medications are approved for chronic weight management.

However, what they are approved for, and whether they are available, varies by country.

When millions of people are using these medications — and billions of dollars are involved — questions about what happens after stopping naturally follow (H1)(H2).

In this episode, we’re focusing specifically on GLP-1–based medications and what the evidence shows about weight regain after stopping them.

🧾RECEIPT CHECK

Let’s check the evidence — our kind of receipt check.

This is the moment to pause and ask the questions that matter — what’s the evidence, what’s the source, and how do we know?

🔬WHAT THE EVIDENCE SHOWS

Here’s what the evidence shows.

A 2026 systematic review and meta-analysis examined weight regain after stopping medications for weight management (E1).

A systematic review pools available research on a topic.

A 2025 systematic review and meta-analysis examined metabolic rebound — meaning changes in weight or metabolic markers — after discontinuing GLP-1 receptor agonists (E2).

Across both reviews, weight regain commonly occurred after discontinuation (E1)(E2).

A 2022 randomized clinical trial followed participants after semaglutide was stopped (E3).

A randomized clinical trial is a study that randomly assigns people to different treatments to reduce bias.

Participants regained about two-thirds of the weight they had lost within one year of stopping (E3).

Blood pressure and cholesterol levels moved back toward pre-treatment levels after stopping, rather than worsening beyond baseline during the study follow-up (E3).

A 2024 randomized clinical trial examined what happened when people continued tirzepatide compared with stopping it (E4).

Participants who stayed on the medication maintained their weight reduction.

Those switched to placebo regained a substantial amount of weight over the next 52 weeks (E4).

Another 2025 systematic review evaluated body habitus after discontinuing GLP-1 receptor agonists (E5).

Body habitus refers to overall body weight and shape.

This review also found that discontinuation was associated with weight regain (E5).

Across studies, weight regain after discontinuation appears common, although the degree and timing vary (E1)(E2)(E3)(E4)(E5).

These trials compared continued medication with stopping; they were not designed to test specific lifestyle strategies after discontinuation (E3)(E4).

🧠WHY THIS TREND RESONATES

So why does this trend resonate?

These medications can lead to meaningful weight reduction during treatment (E3)(E4).

That can feel life changing for many people.

When weight loss happens during active therapy — and regain happens after stopping — it challenges the idea of a simple, one-time solution (E3)(E4).

Many people think of these medications as a short-term reset.

But the evidence suggests their effects persist during treatment and diminish after discontinuation (E3)(E4).

That framing helps explain why conversations about “stopping” generate strong reactions.

🧭THE TAKEAWAY

So what’s the takeaway?

Across systematic reviews and randomized trials, weight regain after stopping GLP-1 medications appears common, while continued treatment supports maintenance (E1)(E2)(E3)(E4)(E5).

Longer-term real-world outcomes remain uncertain (E1)(E2)(E5).

Your Evidence Edit moment:

Strong evidence shows that weight regain commonly occurs after stopping GLP-1 medications, while continued treatment results in maintenance of weight reduction (E1)(E2)(E3)(E4)(E5).

This pattern is consistent across multiple systematic reviews and randomized clinical trials (E1)(E2)(E3)(E4)(E5).

Long-term outcomes beyond study follow-up periods remain an area of ongoing observation (E1)(E2)(E5).

Weight maintenance may depend on continuation, not just initiation.

Clear evidence does not remove complexity, but it reduces confusion.

💭REFLECTION PROMPT

Something to reflect on…
When you hear about a medication that works while taken, what expectations do you have about what happens after stopping?

📬OUTRO & CTA

If you found this useful, follow Beyond the Buzz and share it with a friend who likes a little science with their scroll.

You can also explore the full transcript, the clarity poll, and evidence in The Evidence Edit.

Until next time, stay curious — and stay kind to your mind.

This is Beyond the Buzz — cutting through the hype, because evidence is empowering.

Next week: Placebo Effects in Wellness Practices Explained

📊 POLL

📚REFERENCES — What’s the Hype (H1–H#) / What’s the Evidence (E1–E#)

🔓 Open Access |🔒Paywalled

H1

KFF Health Tracking Poll. (2025). About one in eight adults (12%) say they’ve taken a GLP-1 drug such as Ozempic or Wegovy either to lose weight or treat a chronic condition. KFF. https://www.kff.org/health-costs/poll-1-in-8-adults-say-theyve-taken-a-glp-1-drug-including-4-in-10-of-those-with-diabetes-and-1-in-4-of-those-with-heart-disease/ 🔓

H2

Novo Nordisk. (2026). Obesity care sales of DKK 82.3 billion (+31% at CER). Novo Nordisk. https://www.novonordisk.com/content/dam/nncorp/global/en/investors/pdfs/financial-results/2026/Q4-2025-investor-presentation-4Feb.pdf 🔓

E1

West, S., Scragg, J., Aveyard, P., Oke, J. L., Willis, L., Haffner, S. J. P., Knight, H., Wang, D., Morrow, S., Heath, L., Jebb, S. A. J., & Koutoukidis, D. A. (2026). Weight regain after cessation of medication for weight management: systematic review and meta-analysis. BMJ, 392, e085304. https://doi.org/10.1136/bmj-2025-085304 🔓

E2

Tzang, C.-C., Wu, P.-H., Luo, C.-A., Chen, Z.-T., Lee, Y.-T., Huang, E. S., Kang, Y.-F., Lin, W.-C., Tzang, B.-S., & Hsu, T.-C. (2025). Metabolic rebound after GLP-1 receptor agonist discontinuation: a systematic review and meta-analysis. EClinicalMedicine, 90, 103680. https://doi.org/10.1016/j.eclinm.2025.103680 🔓

E3

Wilding, J. P. H., Batterham, R. L., Davies, M., Van Gaal, L. F., Kandler, K., Konakli, K., Lingvay, I., McGowan, B. M., Kalayci Oral, T., Rosenstock, J., Wadden, T. A., Wharton, S., Yokote, K., & Kushner, R. F. (2022). Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension. Diabetes Obes Metab, 24(8), 1553-1564. https://doi.org/10.1111/dom.14725 🔓

E4

Aronne, L. J., Sattar, N., Horn, D. B., Bays, H. E., Wharton, S., Lin, W.-Y., Ahmad, N. N., Zhang, S., Liao, R., Bunck, M. C., Jouravskaya, I., & Murphy, M. A. (2024). Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity: The SURMOUNT-4 Randomized Clinical Trial. JAMA, 331(1), 38-48. https://doi.org/10.1001/jama.2023.24945 🔓

E5

Berg, S., Stickle, H., Rose, S. J., & Nemec, E. C. (2025). Discontinuing glucagon-like peptide-1 receptor agonists and body habitus: A systematic review and meta-analysis. Obesity Reviews, 26(8), e13929. https://doi.org/10.1111/obr.13929 🔒

🎧 Prefer to listen?
Listen to GLP-1 Medications and Weight Regain After Stopping: What Evidence Shows on the Beyond the Buzz website — or follow Beyond the Buzz in your favourite podcast app.

Educational content only. This publication does not provide individualized medical, psychological, or professional advice.
Full disclaimer: beyondthebuzzmedia.com/disclaimer